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C h a p t e r   1
The application of gated SPECT in 




Coronary artery disease is the leading cause of death in western countries and has a major 
impact on modern society [1,2]. In the latter part of the last century several dramatic changes, 
because of technological advances or improved therapeutic options, occurred in the care and 
management of patients with coronary artery disease. As a result of both new or improved 
diagnostic and therapeutic capabilities, significant chances took place in the population with 
respect to the occurrence of various patterns of ischemic heart disease. The improvement 
in survival after acute myocardial infarction resulted in a markedly increased population of 
patients with more or less extensive cardiac disease. Patients tend to be older and to have a 
more severe extent of disease. The advances in medical management come with an increase 
in cost [3]. Costs have become the major factor in the development and implementation of 
clinical protocols for the management of this patient group [4,5]. In this setting it becomes 
more important to go beyond establishing a diagnosis of coronary artery disease, and towards 
the level of risk stratification [3]. This need for risk stratification applies to patients with either 
acute or chronic coronary artery disease.
Stress test is a technique to assess information about myocardial perfusion. However, under 
certain conditions the sensitivity or the specificity of the stress test dropped to low levels. For 
instance in patients with a history of myocardial infarction, or with an acquired left bundle-
branch block, or in those unable to attain the required exercise level, the electrocardiographic 
criteria often proved too crude [6,7].  Especially in women, the diagnostic power of the stress 
test appeared to be quite disappointing [8-11]. Although some reports indicate that gender-
specific criteria may result in significant improvements [12]
Coronary angiography enables us to assess coronary artery stenosis, wall motion and left 
ventricular ejection fraction (LVEF). Unfortunately this is a costly and invasive procedure. 
Myocardial perfusion scintigraphy provides additional information about myocardial perfusion, 
but with far less anatomical detail. It is essentially noninvasive. Main use of myocardial perfusion 
scintigraphy is in risk stratification and in the assessment of the presence of reversible ischemia 
in patients with known or suspected coronary artery disease. As such it is used as a diagnostic 
pre-filter. It was concluded that patients with either a very high, or a very low prior risk for 
ischemic heart disease should not undergo myocardial perfusion scintigraphy [13] (figure 
1). In a large proportion of patients with an intermediate probability of reversible ischemia, 
no reversible ischemia is actually present. These patients do not have to undergo invasive 
procedures. Such patients are preferably treated with medication only. This management 
strategy proved to be cost-effective in patients at an intermediate risk for cardiac events due 
to coronary artery disease [14-18].
RADIOPHARMACEUTICALS
In the early 70’s thallium-201 (201Tl) was introduced as a potassium analogue [19-21]. It has 
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Although 201Tl performed reasonably well in patients at an intermediate risk, the number of 
patients that were wrongly diagnosed (false positive and false negative combined) still exceeded 
10% [15, 22-26]. Thallium was not an ideal pharmaceutical for perfusion scintigraphy. It has a 
low photon energy (80 keV) and a rather long half-life of 72 hrs. Technetium-99m (99mTc) has 
a half-life of 6 hours and therefore permits the use of a larger amount of radioactivity. Also 
the higher photon-energy (140 keV) results in less scatter and less attenuation. Both factors 
contribute to an improvement in image quality. 
A number of 99mTc-based pharmaceuticals has been developed and introduced for myocardial 
perfusion imaging, based on the assumption that their use would result in an increased image 
quality and thereby a significant improvement in diagnostic performance.  The former proved 
to be true in practice, especially with the use of single photon emission computed tomography 
(SPECT) and more recently the use of gated SPECT. Some studies indicated a reduced number 
of borderline diagnoses especially with the application of gated SPECT technology [27,28]. 
99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile (99mTc-MIBI) was one of the first and most 
successful 99mTc-based pharmaceuticals. Tetrofosmin became available somewhat later in the 
nineties. Its clinical introduction and initial evaluation in humans took place ‘in the wake’ of 
the introduction of 99mTc-sestamibi for myocardial perfusion scintigraphy. Tc-99m-1,2 bis [bis 
(2-ethoxyethyl) phosphinol] ethane, (tetrofosmin, Myoview!, Amersham International U.K.) 
is cationic and lipophilic. The most likely mechanism for the uptake of 99mTc tetrofosmin is by 
potential driven diffusion of the lipophilic cation across the sarcolemmal and mitochondrial 
membranes [29-32]. 99mTc-tetrofosmin shows little if any redistribution. The absence of 
redistribution is the reason for 99mTc-tetrofosmin administration during both stress and rest. 
The uptake in the myocardium is rapid. Approximately 1.2% of the injected dose of 99mTc-
tetrofosmin can be found in the myocardium within five minutes. It remains stable for the first 
hour, then gradually drops to 1.0% at 2 hours and 0.7% at 4 hours. At 24 hours only 0.2% of 
the injected dose was still present in the myocardium. The clearance from the bloodstream is 
rapid, with less than 5% remaining in the blood pool at 10 minutes post-injection. Approximately 
MPS += abnormal MPS study; MPS 
- = normal MPS; ECG += abnormal 
exercise ECG; ECG - = normal exercise 
ECG (adapted from reference 13).
Figure 1.  Pre- and post-test likelihood of  coronary artery disease calculated using Bayesian principles 
for exercise ECG and Myocardial Perfusion Scintigraphy (MPS).
12
66% of the injected dose activity is excreted within 48 hours post-injection with approximately 
40% excreted in the urine. Faecal clearance varies between 17 and 41% with a tendency 
towards lower faecal clearance after exercise [33].
The uptake in many organs was dependent upon the exercise level at the time of injection. The 
uptake in lungs, liver, gallbladder, kidneys, thyroid and gastrointestinal tract all showed a 1.2 
to 2.2-fold decrease in uptake after exercise [33]. Early liver uptake dropped rapidly from 4.9-
10.6% of the injected dose at 5 minutes to less than 1.6% at two hours [33]. The gallbladder 
activity reaches its peak at 2 hours. At rest it can contain up to 11% of the injected dose. 
The relatively high liver activity is the major disadvantage of 99mTc-based pharmaceuticals. 
Therefore, image acquisition starts 45 to 60 minutes after administration. The lung uptake 
is low, resulting in heart-to-lung ratios of 3 to 5 minutes post injection and rapidly improving 
with time [33].
Side-effects are very rarely seen. After intravenous injection a very small number of individuals 
notices a “metallic” taste, or reports mild nausea. To date so far, no serious side-effects have 
been reported [34].
Besides information on myocardial perfusion it is also important to be informed about the 
left ventricular function. The high count density achieved with 99mTc-tetrofosmin and the fact 
that 99mTc-tetrofosmin retains in the myocardium make it possible to analyse left ventricular 
function, even until several hours post injection.
LEFT VENTRICULAR FUNCTIONAL IMAGING MODALITIES
The left ventricular ejection fraction can be derived from scintillation by several different 
diagnostic methods. The ventricular pump function can be measured by imaging the 
cardiac transit of an intravenously administered bolus of radioactivity, first-pass radionuclide 
angiography [35,36]. A bolus of tracer is imaged as it passes through the cardiac chambers. 
End-diastolic (EDC) and end-systolic (ESC) counting rates are measured during left ventricle (LV) 
bolus transit and corrected for the background, represented as a time activity curve. The peak 
shows the heart in end-diastolic phase (ED) and the lowest point of the curve shows the heart 
in end-systolic phase (ES). The left ventricular ejection fraction is calculated by the formula: 
LVEF=(ED-ES)/ED. The ejection fraction is based on the amount of radioactivity (number of 
‘counts’) and is not based on the geometry of the ventricle. 
The second, more commonly used, method is equilibrium radionuclide ventriculography [35]. 
With the latter method autologous red blood cells are labelled with 99mTc-pertechnetate 
resulting in high-contrast imaging of vascular space. ECG triggered (synchronic with the R-top 
signal) data on gated ESC and EDC acquired over several hundred cardiac cycles are summed, 
and corrected for background. Depending on the method of data acquisition the RR-interval 
is divided into 16 to 24 frames. The division of the cardiac cycle into more frames is called 
‘multiple-gating’. Computer programs assess count-rate changes, yielding measurements 
of global and regional ejection fraction, volumes, and emptying and filling rates of left and 
right ventricle [35,37,38]. The analysis of global and regional left ventricular function can be 
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can be assessed by this method and used as a sensitive test for impaired global and regional 
ventricular function.
A number of potential errors that can affect the accuracy of LVEF measurements has been 
explained in literature, such as poor definition of blood pool edges, inadequate gating, 
insufficient separation of left and right ventricles, significant soft tissue attenuation over the 
left ventricle and inappropriate background subtraction [35]. 
Evolution of myocardial function and perfusion imaging.
In 1984 Narahara et al. [39] were the first to report the ability of combining assessment of 
ventricular function and myocardial perfusion during one single test using bicycle exercise. 
Gold-195m with a half-life of 30.5 seconds was used for first pass radionuclide angiography 
(RNA) and thallium-201 was used for the assessment of the myocardial perfusion. Immediately 
after the administration of 2 mCi of thallium-201, approximately 20 mCi of gold-195m was 
injected to obtain an exercise first-transit study that required 30 seconds of acquisition time. 
Within 5 minutes after the acquisition of the first-transit study and the termination of exercise, 
the acquisition of the myocardial perfusion imaging started. Three hours thereafter, the 
redistribution images were obtained.
Verani et al [40] used iridium-191m, with a half-life of 4.96 seconds, for measuring the LV 
function with RNA, a few years later. The myocardial perfusion was measured using 201Tl 
immediately following first pass RNA. Later, several studies reported the use of 99mTc-labeled 
agents to obtain information about the condition and behaviour of ventricular function with 
RNA and myocardial perfusion simultaneously [41,42]. In 1989 Najm et al [43] reported that 
they assessed a method of providing information on the left ventricular function as an adjunct 
to myocardial perfusion imaging using Tc-99m MIBI (2-methoxy-2-methyl-isopropyl-isonitrile). 
Radionuclide fractional shortening was calculated from the anteroposterior and the septum to 
lateral wall axes (on the anterior oblique 45° view) in diastole and systole. Data were acquired 
from 18 frames per cardiac cycle. The global fractional shortening correlated closely with left 
ventricular radionuclide ejection fraction.
The introduction of single photon emission computed tomography (SPECT) [44-46] and the 
continuously improving imaging hardware and reconstruction software allowed the creation 
of three-dimensional images of the left ventricle. The SPECT technique has several advantages 
over planar imaging for the analysis of perfusion and function, such as improved resolution, 
differentiation of overlapping myocardial regions, improved sensitivity and specificity 
of diagnoses, depiction in planes familiar to cardiologists and colour images improving 
interpretation and presentation. Due to these developments the assessment of left ventricular 
function and perfusion during one single acquisition has assumed enormous proportions; In 
1990 Marcassa et al. [47] analyzed regional wall thickening with Tc-99m MIBI with a method 
based on the partial volume effect (the systolic-diastolic changes in the detected radioactivity 
would reflect changes in myocardial wall thickness). The myocardial perfusion images were 
gated in 16 frames per R-R interval. The left ventricular end-diastolic and end-systolic edges 
were manually drawn; this was the only operator-dependent procedure.
Faber et al. (1991) reconstructed a tomographic radionuclide ventriculogram with a 16-frame 
gated SPECT acquisition using 99mTc-MIBI and a cylindrical co-ordinate system was used to 
determine left ventricular surface points [48]. Global variables, such as volumes, ejection 
fraction, and myocardial mass were computed. Otherwise from asking the user to identify 
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the left ventricular long axis, the method was entirely automatic. The automatically calculated 
motion and perfusion values from gated SPECT images were validated by comparing them 
with those determined from hand-traced surfaces of cardiac rotation magnetic resonance (MR) 
images. In 1993 DePuey et al. [49] reported on the calculation of the LVEF using an 8-frame 
gated SPECT myocardial perfusion acquisition after injection of 99mTc-MIBI. The endocardial 
borders were manually drawn at a count level of 34% of the maximum. The LVEF was 
derived from end-diastolic and end-systolic endocardial borders. LVEFs calculated from gated 
MIBI SPECT ranged from 0.21 to 0.73 and correlated linearly with gated blood-pool values 
with correlation coefficients ranging from 0.79 to 0.88. Intra-observer and inter-observer 
reproducibility in determination of LVEF from gated MIBI SPECT were suboptimal (r=0.75).
Hambye et al. [50] reported in 1997 on ECG-gated SPECT imaging. Eight time-frame gated 
SPECT data was collected, using 99mTc-sestamibi. Ejection fraction was calculated using 
a semiautomatic edge-detection technique based upon a threshold-searching method and 
compared with values obtained from first-pass or equilibrium radionuclide angiography. End-
diastolic and end-systolic bins were selected manually by the observers on a short-axis image, 
using a colour cine-loop display. End-diastolic and end-systolic endocardial borders were drawn 
automatically on the mid-ventricular vertical (VLA) and horizontal long-axis (HLA) images at 
80% of the maximum profile activity. An elliptical interpolation was applied at end-diastole 
and end-systole between the borders determined on these orthogonal slices to calculate the 
corresponding volumes. In patients with regions of severely impaired perfusion, especially those 
involving extended regions of the left ventricle, the thresholding algorithm was unable to draw 
the endocardial border accurately and therefore manual determination was necessary. Despite 
slight discrepancies between gated SPECT with other radionuclide angiographic methods at 
extreme LVEF values (under- or overestimation with gated SPECT for absolute values below 
40% and over 65% respectively), there was a good correlation observed over a wide range of 
values. Good reproducibility was noted, with an inter- and intra-observer variability of "0.2 ± 
3.5 (range "7.6 to 6.9%, r=0.97) and "0.2 ± 2.2% (range "5.9 to 3.5%, r=0.99) respectively.
In that same year, Calnon et al. [51] developed a new gated SPECT method for computing the 
global LVEF based entirely on changes in maximum regional myocardial counts during systolic 
contraction, independent of endocardial edge detection or other geometric measurements. By 
quantifying the changes in maximum pixel counts (partial volume effect), regional systolic wall 
thickening could be assessed.
QUANTITATIVE GATED SPECT (QGS).
introduction
A disadvantage of the described techniques to acquire left ventricular function is the non-
automatic delineation of the myocardial border and hence operator dependency which may 
lead to a higher inter-observer variability compared to a totally operator independent method. 
Germano et al. [52-59] developed a complete automatic algorithm: quantitative gated SPECT 
(QGS).  With this method it is possible to quantify the left ventricular cavity volumes, the left 
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Figure 2. Left: Screen display with short and long axis images with overlaid endocardial and epicardial 
contours. 
Short axis images are used as input. under: Four dimensional (three dimensional plus time) display screen 
utilized for the assessment of global and regional myocardial function. Gated short axis images are used 
as input.
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This algorithm uses gated short-axis data sets after stacking them together to form a three-
dimensional image volume (figure 2). 
Automatic segmentation of the left ventricular myocardium will take place, based on initial 
heuristic thresholding, binarization, and clustirification of the three-dimensional image, 
followed by iterative cluster refinement using pixel erosion and pixel growing (repetitive 
dilatation). The classical Hough transform is applied to detect contiguous local maxima forming 
approximate circles [60,61]. Each circle is assigned a score proportional to the average count 
value along its circumference and the ratio of that value to the average count at the center, 
so as to favour doughnut-like count distributions. The circle with the highest score is deemed 
the most likely to represent the left ventricle and is expanded by 2 pixels outwards. For three-
dimensional short-axis volumes, all voxels outside the cylinder with that circle for section are 
discarded. Once the left ventricle has been isolated and its centre of mass is automatically 
determined, rays are drawn from it according to a spherical sampling model. From this a 
first estimate is defined of the three-dimensional midmyocardial surface, which is then fitted 
to an ellipsoid. The best-fit ellipsoid defines new sampling co-ordinate system, along which 
count profiles normal to the myocardium are measured and fitted to asymmetric Gaussian 
curves. Endocardial and epicardial surfaces are determined based on the Gaussians’ standard 
deviations. The valve plane is determined by fitting a plane to the most basal myocardial 
points. Contours are generated even in apparent absence of perfusion because Gaussian 
fitting operates on the segmented but non-thresholded image, and is thus able to discern 
very low levels of perfusion. Thereby, contours are generated by maximazing the smoothness 
of the surface patch defined by the invalid points (extrapolating those of points immediately 
adjacent to the nonperfused area) [52-59].
Left ventricular volumes are calculated by straight summation of the volumes of the voxels 
bound by the endocardium and the valve plane. The LVEF is derived from the end-diastolic 
and end-systolic cavity volume, all without operator interaction [52-59]. The relation between 
8 frame and 16-frame measurements of gated SPECT LVEF has been investigated for QGS 
algorithm [53]. Due to the smoothing of the time-volume curve, the 8-frame gating was shown 
to somewhat underestimate LVEF (3.7 LVEF percentage points compared to 16-frame LVEF 
gating). The degree of underestimation is remarkably uniform over a wide range of ejection 
fractions.
Regional wall motion is the excursion of the three-dimensional endocardial surface from end-
diastole to end-systole. Segmental thickening is calculated using both geometric and count 
considerations (partial volume effect) [52-59].
Gated SPECT takes full advantage of the properties of 99mTc perfusion agents, namely high 
count rates and stable myocardial distribution with time. Because the tracer distribution in the 
myocardium is stable, spatial and temporal changes in the myocardial tracer activity during the 
cardiac cycle reflects regional myocardial wall motion and wall thickening.  An advantage of 
this technique is the possibility to assess perfusion and function during one single acquisition.
Gated SPECT imaging validation by other methods.
Functional data on the left ventricle acquired by the gated SPECT technique has been compared 
with other well-known imaging modalities such as magnetic resonance (MR) imaging, contrast 
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reported a good to excellent agreement between these imaging modalities and gated SPECT. 
Bavelaar-Croon et al. [70] found a correlation coefficient of 0.85 for the LVEF measured by gated 
SPECT as compared to MR imaging. They also found an excellent correlation coefficient for 
both the left ventricular end-diastolic volume (LVEDV) and left ventricular end-systolic volume 
(LVESV): r=0.94 and r=0.95 respectively. Higher mean LVEDV and LVESV were measured by 
gated SPECT as compared to MR imaging, but the differences were not significant. This finding 
is due to inclusion of part of the outflow tract with MR imaging. Vaduganathan et al. [66] 
found in 25 patients with an acute myocardial infarction an exact agreement for wall motion 
scores in 92% of the segments with a kappa of 0.82 between gated SPECT and MR imaging. 
Correlations between the two techniques were also good for LVEDV, LVESV and LVEF resp. 
r=0.81, r=0.92 and r=0.93. Atsma et al. [69] compared LVEF data acquired by gated SPECT 
and LVEF measured by contrast ventriculography in 74 patients. The authors found a good 
correlation (r=0.84) between the two imaging modalities. They also found exact agreement of 
segmental wall motion scores on a 4-point scale in 89% of the segments with a kappa value 
of 0.76. Bacher-Stier et al. [67] reported a correlation coefficient of 0.86 between the LVEF 
measured by gated SPECT and echocardiography in rest. Moreover, using echocardiography 
as reference standard, regional wall motion abnormalities were identified by gated SPECT with 
high sensitivities (88%-100%) and high specificities (82%-98%). 
Quantative Gated SPECT, the version used in this thesis.
Visual interpretation of myocardial wall motion and wall thickening has been shown to 
provide important diagnostic and prognostic information in various groups of patients with 
known or suspected coronary artery disease [72]. However, substantial operator dependency, 
intraobserver and interobserver variability in interpretation compromise the reproducibility 
of non-automatic and non-quantitative techniques. Germano et al. [54,73] has developed 
a new approach to a quantitative analysis of the regional wall motion and wall thickening. 
The algorithm uses also ellipsoid fitting and sampling of the myocardium and generates 
non-slice-based analysis of relative myocardial perfusion, independent of the size, shape, 
and orientation of the left ventricle. In addition to a numeric measurement of the extent, 
severity, and reversibility of perfusion defects, the approach provides automatic, computer-
derived segmental scores, analogous to the semiquantitative 20-segment, 5-point (0-4) visual 
scores model, and the option for building customized normal databases. Perfusion at each 
myocardial sampling point was calculated as the average uptake along the count activity profile 
(endocardial-epicardial segment) normal to the myocardium and passing through that point 
[54,56,58,73]. Endocardial and epicardial surfaces were derived even in areas of apparent 
absence of perfusion using rule-based criteria ensuring the continuity of surface myocardial 
count profiles (as described above) [56,58]. Normal limits and abnormality criteria for relative 
myocardial uptake, for each of the 20 myocardial segments, seen during stress 99mTc-sestamibi 
imaging and rest 201Tl imaging were developed [56,58,73]. This thesis is based on Cedars-
Sinai’s Quantitative SPECT (QGS) software program developed by G. Germano (version 2.0, 
revision A”figure 2) [52].
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CONSIDERATIONS AT THE START OF THE STUDY 
Diagnostic value of gated SPECT myocardial perfusion imaging.
The sensitivity of exercise perfusion imaging for detecting angiographicaly significant CAD 
ranges from 85-91% [13]. The specificity ranges from 70-94%. The addition of SPECT to 
exercise testing increases the diagnostic accuracy to detect CAD, with no significant differences 
between men and women [74-76]. Factors that effect the diagnostic performance are referral 
bias [76], reduced stress tolerance [77,78], anti-angina medication [79-80], imaging problems 
like tracer activity below diaphragm [81,82], photon attenuation and scatter, patient motion, 
low count statistics, reconstruction artifacts [23]. It can be such a large bias that it is likely 
to have a negative impact in discussions on the role of perfusion scintigraphy in patient 
management.
The addition of left ventricular function parameters assessed by gated SPECT has improved 
the diagnostic value [27,28]; as an attenuation artifact usually will show a fixed perfusion 
defect with concomitant preserved wall thickening and/or motion, whereas a region with a 
fixed perfusion defect due to myocardial infarction will show absence of wall thickening and 
or motion. Gated SPECT may show absence of wall thickening potentially indicating necrosis 
or stunning, and conversely, gated SPECT may show concomitant preserved wall thickening in 
the infarct region suggesting preserved viability. 
Potential limitation of perfusion imaging is the measurement of relative myocardial blood flow, 
rather than absolute blood flow. In patients with multivessel CAD, the degree of ischemia may 
be underestimated because of globally reduced perfusion of the left ventricle. Overall sensitivity 
for identifying any SPECT abnormality of the combined perfusion/ function assessment in 
three vessel disease is 80-95%, and for two or single vessel disease 92% and 86%, respectively 
[83-85].  The overall specificity is 72% [85]. 
Transient ischemic LV dilatation (TID) on myocardial perfusion imaging indicates a significant 
enlargement in LV size on the stress images compared with the rest images. Abnormal TID 
is related to a greater amount of ischemic burden as wel as multivessel-type or LAD territory 
perfusion abnormality [86-88].
In the line of risk stratification viability assessment is an important subject. For example, in 
patients with established extensive coronary artery disease, it is considered worthwhile to 
salvage even small areas with viable contractile cells [89]. However, revascularisation in patients 
with extensive coronary artery disease is associated with a considerable risk of periprocedural 
complications, so it is only justified in patients with remaining viable but dysfunctional 
myocardium [90,91].
Several imaging modalities are potentially available. Positron emission tomography can be 
used to detect areas of increased 18F-fluoro-deoxy-glucose (FDG) uptake, as a prove of altered 
glucose metabolism. Alternatively, the gated SPECT technique can help distinguish contractile 
from non-contractile myocardial tissue at places with borderline perfusion [92]. Improvements 
in local perfusion after specific therapy is taken as conformation of viability. 
The main use of myocardial perfusion imaging is in the assessment of the presence of 
reversible ischemia, as such it is used as a diagnostic pre-test for coronary angiography. The 
prognostic side of myocardial perfusion imaging, as extra information on a diagnostic study, is 
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more structural manner for the management of patients with coronary artery disease. Patients 
with a very low probability [<1 % per year] for cardiac events can be discharged from follow-
up. This management can lead to a gain in efficacy and cost-effectiveness. The evaluation of 
the incremental prognostic value of the left ventricular ejection fraction, as can be obtained 
from gated SPECT data, may be important for the risk stratification of patients with extensive 
coronary artery disease.
Subpopulations
Myocardial perfusion scintigraphy is used for a wide range of distinct clinical purposes 
(subgroups). Among these subpopulations the relative frequencies of certain findings, and 
thereby both the prognostic value, and the diagnostic performance of perfusion imaging will 
vary enormously. For instance, the majority of the data on prognostic value of the parameters 
assessed by gated SPECT has been obtained in a mixed gender population and may not be 
applicable to women. Women often have smaller LV volumes. It has been shown that gender 
related differences in normal limits exist [93-95]. In addition, a multicenter phantom study 
showed a wide range of results in different standard end-systolic and end-diastolic volume 
combinations. Moreover, the LV ejection fraction (LVEF) was overestimated and both the end-
systolic volume (ESV) and end-diastolic volume (EDV) were underestimated. Especially, this is 
the case for small volumes. Cutoff values for LV functional parameters should be validated in 
each center [95]. 
As the case mix varies from institution to institution, the interpretation of pooled data is 
difficult at best [96]. 
The importance of rigorous and extensive reporting at the subgroup level, especially for risk 
assessment, was emphasized in an invited commentary in the American Journal of Epidemiology 
[97].
THE LEIDEN TETROFOSMIN DATABASE 
At the Leiden University Medical Center 201Tl was routinely used for myocardial imaging until its 
replacement by 99mTc-tetrofosmin. After a trial period, tetrofosmin is being used in all patients 
referred for myocardial perfusion scintigraphy since August 1995. In addition to some basic 
demographic data, relevant clinical parameters, from the medical history or on the level of 
exercise reached during the stress test are reported in a well-standardised manner. Reporting 
was routinely performed by an experienced nuclear medicine specialist and a cardiologist in 
consensus reading. Since November 1997, the patients underwent imaging according the 
gated SPECT technique routinely. 
All data were systematically and prospectively entered in a computerised database, that on 
July 1st 2000 held data on more than 2350 procedures in over 2000 patients.
Where available, data was added on any angiography procedure, angioplasty procedure or 
coronary bypass operation performed prior to or shortly after the scintigraphic procedure.
This extensive database, including follow-up data, formed the basis for the studies presented 
in this thesis.
20
AIM AND OUTLINE OF THE THESIS
The aim of the thesis is to further expand our insights in the prognostic and diagnostic value of 
myocardial perfusion imaging using the gated SPECT technique according to the Cedars-Sinai’s 
Quantitative Gated SPECT (QGS) software [52].
We studied the robustness of the QGS technique, assessing the quantitative segmental score 
of wall motion, wall thickening and left ventricular volumes. Following this validation, the 
additional prognostic value of gated SPECT on subgroup level was investigated.
In Chapter 2 we evaluated the reproducibility and operator dependence for the quantitative 
regional left ventricular functional parameters assessed by Cedars-Sinai’s Quantitative 
automated gated SPECT  (QGS) software. 
In Chapter 3 left ventricular function parameters at rest were compared to LV function 
parameters 30 minutes post-stress in patients with a myocardial infarction: evaluation with 
gated SPECT.
In Chapter 4 the prognostic value of gated SPECT in patients with a left bundle branch block 
was evaluated.
In Chapter 5 we evaluated the additive prognostic value of perfusion and functional parameters 
assessed by gated SPECT in women.
In Chapter 6 a review is presented of the relevant literature on prognostic value of gated 
SPECT imaging.
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ABSTRACT
Objectives: To evaluate the reproducibility and operator dependence for the quantitative 
regional left ventricular functional parameters (LVFP) assessed by Cedars-Sinai’s Quantitative 
automated gated SPECT (QGS) software.
Methods: The QGS algorithm was reviewed in detail and potential operator dependencies were 
defined. Series of prototypes were selected, consisting of a) normal perfusion, b) perfusion 
defects in all perfusion regions, c) perfusion studies of patients with angiographic confirmed 
normal coronary arteries, proximal ( >70% stenoses) single and multiple vessel disease, and d) 
spurious activity in close proximity. While defining and re-orienting the volume containing the 
left ventricle, the operator adjusted 8 variables/ degrees of freedom (DF). The software was 
used without further operator interventions. Results were expressed as a coefficient of variation 
(COV). Separate COV were calculated per distinct DF. A segment was considered not robust 
when the COV did exceed 20% in a single DF, 15% in at least 2 DF, or 10% in at least 3 DF. 
Results: Regional left ventricular EF and volumes showed excellent reproducibility.
Normal perfusion and the vessel disease prototypes showed an excellent COV (for all 
re-orientation steps [33/prototype]) mostly below 5% for LVFP. However, regional wall motion 
and thickening became less reliable in the presence of large perfusion defects or artifacts. 
Conclusions: Quantitative estimates for regional left ventricular functional data show excellent 
reproducibility using automated gated SPECT. However, there may be substantial operator 
dependency in the presence of large defects or spurious activity in close proximity. 
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INTRODUCTION
Techniques for automated quantitative approach of myocardial perfusion imaging have been 
developed and refined over the past decades. Automation and quantitation in nuclear cardiology 
are important to minimize inter- intra operator variability and increase reproducibility [1]. New 
quantitative image processing software should undergo systematic independent evaluation 
and thorough search for clinical conditions under which the underlying algorithms may fail or 
loose precision. With regard to the validation of the Cedars-Sinai’s Quantitative SPECT (QGS) 
software, several requirements have already been met. The algorithm and its basic validation 
have already been described [2-15]. However, one particular issue is still not fully solved: 
reproducibility of the quantitative assessment of regional functional parameters in the presence 
of severe major defects or artifacts. In cross-validations with other techniques, results have 
been evaluated on population level. Any failure in specific subgroups will be diluted by the large 
amount of successful analysis over the investigated population. The software used in the QGS 
technique is complex and, under certain conditions, falls back on alternative algorithms. This 
complexity makes cross-validations with other techniques difficult. Therefore, our assessment 
was based on a system analyses to test the reliability of the quantitative assessment of the 
left ventricular volumes (end-diastolic and end-systolic), LVEF and regional segmental wall 
motion and wall thickening. In this approach we tried to identify conditions under which the 
algorithm becomes operator-dependent. We especially reviewed the algorithm for interfering 
clinical conditions, such as large perfusion defects, activity below the diaphragm and operator-
dependent factors in the image processing. The operator-dependent factors contain only the 
reorientation that the operator has to perform after raw data acquisition. The rest of the data 
processing can easily kept constant, is assumed to be stable.
Assessment of the average defect size in a representative population from our institution 
showed that of the total population one third has a large perfusion defect defined as 7 or 
more hypoperfused segments using a 20-segment model (figure 1). This indicates that this is 
a very large patient group. 
The aim of this study was to evaluate systematically the reproducibility of all quantitative 
functional results of the QGS-software program.
N= 2536 consecutive myocardial perfusion 
studies using 99mTc-tetrofosmin between 
April 1995 and July 2000.
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METHODS
Study population.
Seventeen patients were selected who underwent 99m-Technetium (tetrofosmin) gated SPECT 
myocardial perfusion scintigraphy at the Leiden University Medical Center between November 
1997 and 1 January 2000. Study selection was partially based on the findings of the system 
analysis: based on clinical conditions and operator-dependent factors (described below). This 
selection was supplemented to cover a representative range of defect sizes, locations and 
artifacts on perfusion imaging studies. The selection resulted in examples of studies with 
isolated perfusion defects in all different regions of the left ventricle, spurious activity below 
the diaphragm and left ventricle aneurysm. A second series was selected based on findings at 
coronary angiography. For each unique constellation of defect, artifact, stenosis or combination 
thereof, a typical example (a so-called prototype) was selected. 
Patients with severe perfusion defects or severe angiographic stenosis were selected, as this 
represents the worst-case scenario for the software. Each prototype was subjected to the 
analysis, as described below. Global characteristics of the selected prototypes are shown in 
table 1. 
Table 1. Global characteristics of the selected prototype studies used in the assessment of robustness.
Prototype EDV ESV LVEF Rejects Defects Perfusion/ Angiographic findings
A 86 38 56 0 0 normal perfusion
B 210 116 45 0 7 inferior defect
C 104 76 27 0 7 anterior defect
D 158 91 43 0 2 infero-lareral defect 
E 92 46 50 0 8 antero-septal defect
F 199 132 33 4 8 apical defect
G 315 269 15 0 10 large defect*
H 247 207 16 0 12 aneurysm
I 178 124 30 19 5 activity below diaphragm
J 94 45 52 0 2 normal coronary arteries
K 222 163 27 2 8 proximal LAD stenosis 
L 210 148 30 3 11 prox. LAD, RCA stenosis
M 183 135 26 0 5 prox. LAD, RCX stenosis
N 56 14 76 0 0 prox. RCA stenosis
O 135 67 50 0 3 prox. RCA, RCX stenosis 
P 78 21 73 0 0 prox. RCX stenosis
Q 105 51 52 0 0 3 vessel disease
EDV =end diastolic volume [ml]; ESV =end systolic volume [ml]; LVEF = left ventricular ejection fraction 
[%]; Rejects: number of analyses out of 33, rejected because of obvious misfit on visual inspection. 
Defects: number of segments with uptake below 40% on automated end systolic bull's eye projection 




Myocardial perfusion scintigraphy was performed using 500 MBq 99mTc-tetrofosmin, as 
previously described [16]. Stress images (bicycle exercise, or adenosine 0.14 mg/kg/min for 
6 minutes, or dobutamine up to 40 µg/kg/min) and rest images were obtained. Shortly 
after injection of tetrofosmin the patient was instructed to drink some milk to stimulate and 
accelerate hepatobiliary clearance. All gated acquisitions took place with the patients in prone 
position, 30-45 minutes (stress) or 45-60 minutes (rest) post-injection. Imaging was performed 
with a triple-head 360° rotating gamma camera equipped with high resolution collimators (GC-
9300 GMS, Toshiba, Japan). A total of 90 frames of 30” duration in a 64 x 64 pixel matrix were 
obtained at 4° intervals using a non-circular orbit. Sixteen bins per cardiac cycle were acquired. 
All studies were prefiltered with a 9th order Butterworth filter with a cut-off frequency of 0.26 
cycles/pixel. Filters were kept constant for all studies. No attenuation correction was applied. 
Quantitative gated SPECT analysis.
Gated SPECT analysis was performed using the Toshiba implementation of the QGS-software, 
version 2.0, revision A”. In which quantitative assessment of end-diastolic and end-systolic 
perfusion, wall motion and wall thickening using the 20-segment bull’s eye representation 
of the QGS model [figure 2], as well as estimates for end-diastolic (EDV) and end-systolic 
(ESV) ventricular volume and derived stroke volume and LVEF is incorporated. The underlying 
algorithms have been reviewed in literature [2-13,17]. The software algorithm implementation 
is the same in the different camera systems. Volumes were expressed in milliliters (ml), wall 
motion in millimeters (mm), with a reported 
accuracy of 0.1 mm, whereas wall thickening 
was expressed as a percentage of the fitted 
end-diastolic thickness. 
Coronary angiography
Coronary angiography was performed 
according to the standard Judkins technique. 
An obstruction in 1 of the 3 major epicardial 
coronary arteries of >70% on visual 
examination was considered significant. 
For this study, coronary angiograms were 
only evaluated if they had been performed 
within 90 days after myocardial perfusion 
scintigraphy. Only proximal coronary artery 
stenosis were included. Proximal stenosis were defined as: left anterior descending coronary 
artery (LAD): proximal of the first diagonal branch; Left circumflex artery (LCX): proximal of 
the obtuse marginal branch; and right coronary artery (RCA): from the origin till the second 
acute marginal branch.
Figure 2. The 20 segment bull’s eye model of the 
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Statistical analysis.
Systems analysis. The QGS algorithms and the entire acquisition- and filtered backprojection 
procedures were systematically studied, to identify error-sources that could potentially result in 
loss of precision of the QGS algorithms. This effort was specifically aimed at: 
1.  identifying clinical conditions, such as large perfusion defects; the presence of significant 
amounts of activity below the diaphragm; or anatomical variations, which could interfere 
with the reliability of the algorithms; 
2.  identifying operator-dependent factors in the image processing that could be rigidly and 
reproducibly standardized; 
identifying operator-dependent factors in the image processing that could not be standardized 
in a fully reproducible manner. 
Our approach was essentially a system analysis. The system analysis revealed that the software 
applied several alternative algorithms, to initially detect and preliminary establish exact 
location, orientation, size and crude shape of the left ventricular cavity. The choices made by 
the software are dependent on relative count density, location and intensity of spurious activity 
in, for example, liver, intestines, spleen, lungs, or stomach, as well as on the extent and level 
of uptake of the segments of reliably detected myocardium. For many of these effects, it could 
be deduced that the size, shape, orientation and location of the operator defined bounding 
box (reconstruction slices in which the left ventricle is situated) could potentially influence the 
choices made by the program and hence could result in variation in quantitative results for wall 
motion, wall thickening, EDV, ESV and LVEF. Due to the complexity of the software, it was 
not possible to reliably predict the choices made by this software under various conditions. 
Hence the systems analysis resulted only in global and qualitative, rather than specific and 
quantitative descriptions of conditions that might lead to failure due to excessive operator 
dependence. Results from this analysis were used to select representative clinical studies for 
further robustness analysis.
Criteria for defect size (extent) and severity. 
Criteria on normal perfusion studies were described earlier [18, 19]. Based on an earlier analysis 
[7, 20], it was concluded that segmental uptakes below 40% in the QGS 20-segment end-
systolic perfusion quantification corresponded best with severe perfusion defects. The extent 
of the perfusion defect is the summation of all segments with a severe perfusion defect. 
Seven or more segments with severe compromised perfusion in the 20 segment bull’s eye 
were defined as large. This corresponds with # 26% myocardial abnormality according to the 
method described by Berman et al. [21].
Operator dependence. 
When making the reconstruction for QGS analysis the operator has to set a range of 
reconstruction parameters, forming a sort of bounding box in which the left ventricle is 
situated. During this procedure the operator has to set 8 degrees of freedom (see below). 
For each individual prototype, an initial representative reconstruction and QGS analysis was 
performed followed by repeat reconstructions and QGS analyses, in which a single parameter 
(a degree of freedom) was systematically varied. These parameters defined the size, location 
and angular orientation of the bounding box of the data subset of the entire reconstruction 
volume that was made available to the QGS software. The following parameters were varied:
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1.  angle of rotation in the transversal plane: +20°, °+10°, -10°, -20°;
2.  angle of rotation in the sagital plane: +20°, °+10°, -10°, -20°;
3.  horizontal translation of the selected bounding box: +4, +2, -2, and -4 voxels;
4.  vertical translation of the selected bounding box: +4, +2, -2, and -4 voxels; 
5.  translation along the long axis: +4, +2, -2, and -4 voxels; 
6.  variation in width of the bounding box: +4, +2, -2, and -4 voxels; 
7.  variation in height of the bounding box: +4, +2, -2, and -4 voxels; 
8.  variation in length of the bounding box: +4, +2, -2, and -4 voxels; 
In some instances, visual inspection showed an obvious failure of the QGS software to fit the 
model to perfusion data. These cases were excluded from further analysis. All parameters that 
could be standardized between studies were kept constant.
For each individual segment, or EDV, or ESV, or LVEF, the spread in results due the systematic 
operator-dependent variation in size, orientation and location of the bounding box was 
expressed as a standard deviation [SD]. This was done both for wall motion and wall 
thickening. Each standard deviation was also expressed as a percentage of the respective 
average (coefficient of variation, [COV]), for a completely normal reference study. 
This preliminary analysis resulted in 16 bull’s eye representations of segmental operator 
dependence; one for each of the 8 degrees of freedom controlled by the operator, and one 
each for wall motion and wall thickening. This analysis was performed for all prototypes.
Integration of results.
For reasons discussed in detail below, the 8 degrees of freedom were not considered to be 
statistically fully independent. The results from each set of 8 different bull’s eye images were 
used to generate a bull’s eye representation, indicating -per segment- whether its quantitative 
results were considered reproducible for that particular prototype. Two sets of rules were 
used, for reasons described below: 
-  one set was based on the COV for each segment;
-  the other set used absolute values for the SD for wall motion and wall thickening.
The rules used to assess reproducibility per segment were:
1.  If the COV exceeded 20% in at least one degree of freedom, lack of reproducibility was 
concluded;
2.  If the COV exceeded 15% in at least two degrees of freedom, lack of reproducibility was 
concluded;
3.  If the COV exceeded 10% in at least three degrees of freedom, lack of reproducibility was 
concluded.
4.  If the SD exceeded 1.0 mm (wall motion), or 10% (wall thickening), lack of reproducibility 
was concluded;
5.  If the SD exceeded 0.75 mm (wall motion), or 7.5% (wall thickening) in at least 2 degrees 
of freedom, lack of reproducibility was concluded;
6.  If the SD exceeded 0.5 mm (wall motion), or 5% (wall thickening) in at least 3 degrees of 
freedom, lack of reproducibility was concluded.
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Criteria for reproducibility.
To our knowledge, no criteria have been previously published to define clinically relevant 
uncertainties or inaccuracies regarding the exact quantification of regional wall motion and wall 
thickening. Basically 3 different types of criteria were available: 1) COV, based on the observed 
averages in the same study; 2) COV, based on observed averages in normal studies; and 3) 
SD, without reference to the average values of either the same study, or normal studies. It is 
obvious that COV, based on observed averages in the same study has little value. For example 
in the presence of akinesia, locally segmental COV for wall motion will become extremely high, 
even though the absolute SD is quite modest. The COV, calculated using observed averages 
in normal studies is more meaningful for most segments, but not for all. For example, the 
wall motion in basal septal segments is very small and hence the COV will become high. This 
obviously has no clinical significance. We therefore have chosen to apply a mixed technique. 
For the majority of the segments criterion 2 is the preferred choice. Where a segment failed 
criterion 2, we reported on criterion 3 too. It is obvious, given the considerable anatomical 
variation in size, shape and orientation of the left ventricle, that reference values will show 
relatively large variation, when expressed as COV, at the basal and septal sides of the ventricle. 
For this reason we considered a segment in the basal and septal region not robust when both 
the COV and SD are not robust. 
A recent publication by Sharir et al [17] may provide some guidance, as the normal variation 
between normal subjects sets an upper limit to the variation encountered in normal subjects. 
On average the segmental values for standard deviation for wall motion and wall thickening 
in this group both corresponded to approximately 20% COV. This number was taken as the 
upper acceptable limit for operator-dependent within-prototype segmental variation when 
using the COV methods (criteria 1, 2 and 3 in the section above). 
With regard to the criteria based on the observed segmental variation (SD), two assumptions 
led to similar thresholds. The final values were 1.0 mm and 10% for robustness of wall 
motion and wall thickening. First, it was considered reasonable to attribute at most half of 
the between subjects segmental variation to operator dependent variation in processing. 
Secondly, a detailed analysis of the relation between cut-off value and number of rejected 
segments revealed that for wall motion a limit of between 0.9 and 1.6 mm resulted in a clear 
separation of obviously robust and obviously non-robust studies. For wall thickening, a similar 
analysis showed that over a very wide range of cut-off values for severity of perfusion defect 
(25 - 55%), a cut-off value of 10% for maximum allowable variation (expressed in SD) in wall 
thickening did not result in any changes in the number of rejected segments.
As mentioned above, a COV exceeding 20% at the basal segments is meaningless if the 
normal wall motion at such segment is, for example, only a modest 1.5 millimeter, as no 
clinician would demand a 0.3 mm reproducibility from gated SPECT technology. Furthermore, 
the smallest angle between the long axis of the left ventricle and the valvular plane shows 
considerable variation. This adds to the arguments in favor of selectively applying criterion 3 




Table 1 describes the 17 selected prototypes with regard to extent and severity of perfusion 
defect and, if applicable, the matching angiographic data. In addition, the EDV, ESV and LVEF 
are also given in table 1. 
For each prototype, summary bull’s eye representation for robustness of segmental wall motion 
and wall thickening is given in figures 3A-Q. In these bull’s eye representations, segments that 
were not robust based on the COV criteria are marked accordingly. Where applicable, those 
segments not considered robust based on both COV and SD criteria are identified.
Table 2 gives results per prototype for end-diastolic, end-systolic, LVEF, and an indication on 
the robustness of each measure for each prototype. The mean values for EDV, ESV and LVEF 
were respectively 157 ml, 103 ml and 41%.
Operator dependence
Figure 4 shows a typical example of how quantitative results per segment per degree freedom 
result in the summary bull’s eye maps for COV and SD. In this figure the 2 summary bull’s-eye 
representations for each individual degree of freedom are shown. In case of a typical study 
showing normal perfusion (figure 3A), all segments (beside this, also the EDV, ESV and LVEF 
values) are robust, except for the segments at the basal edge, which is not robust, based on 
COV. Analysis based on COV most other prototypes are not robust at the basal edge, especially 
at the septum. For the analysis based on SD only operator dependence in the basal area in a 
few segments are seen. A clear hierarchy seems to exist regarding robustness of the global 
parameters, with EDV being most and ESV being least robust. With regard to the segmental 
wall motion and wall thickening results, in general, only a poor correlation was found between 
defect size or location and the number and location of segments showing large variation. In 
case of very large defects the variation at the center of the defect tends to be minimal, unless 
spurious activity is close to the defect. 
DISCUSSION
Our results show excellent reproducibility for left ventricular function parameters using the 
Cedars-Sinai’s Quantitative Gated SPECT software. However, large perfusion defects, or the 
presence of spurious activity near the left ventricle may increase operator dependence. 
The QGS software relies on a series of assumptions that cannot be fully tested under 
experimental conditions. Therefore systematic comparison with other imaging modalities is 
important. Several groups have compared the quantitative results from the QGS software with 
similar results from other modalities. Generally in mixed datasets, the concordance with regard 
to the LVEF is good for contrast ventriculography and ultrasound techniques [6-9]. Similarly, the 
concordance with regard to wall thickening is quite good [12]. Some data are also available on 
wall motion, but these data are usually limited to the use of an ordinal scale, rating wall motion 
as normal, hypokinetic, akinetic or dyskinetic. When using this ordinal scale, concordance 
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Figure 3. The Bull’s Eye representations of the Prototypes A-Q.
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so far, however focused on global comparisons in heterogeneous groups of patients, thereby 
diluting systematic discrepancies in case of specific defects or artifacts. Hence such studies are 
unsuitable for the validation of gated SPECT quantitation in the presence of defects. To our 
knowledge, so far no calibrated phantoms exist that can simulate major defects or artifacts. 
In this study we focused on the operator dependent factors in image processing, which are 
not easily kept constant. Filtering of data or positioning of the patient, for example, can 
be well standardized and therefore this was not evaluated in this study. Evaluation of the 
algorithm revealed that the size, shape, orientation and location of reconstruction slices are 
operator dependent factors that are hard to keep constant, and therefore potentially influence 
the choices made by the program in processing the quantitative results for wall motion, wall 
thickening, EDV, ESV and LVEF. 
Prototypes. 
It is difficult to evaluate the effects of certain types of defects on quantitation in a reproducible 
manner. Some arbitrariness will remain regarding the choice of suitable reference studies. We 
have explicitly chosen studies that showed complete perfusion defects during scintigraphy 
or significant stenoses at coronary angiography as a starting point. We assumed that the 
algorithms are less likely to be affected in case of similarly sized defects, with only moderately 
decreased perfusion. In this respect the selected studies can be considered as worst case 
scenarios for the algorithms used. Only in case of extensive areas of lack of robustness did we 
add studies showing decreased, but not absent perfusion. There is a little known about cut-
Table 2. Robustness of the left ventricular volumes and EF.
Prototype EDV ESV LVEF
COV SD COV SD COV SD
A 0 0 0 0 0 0
B 0 0 1$ 0 0 0
C 0 0 1* 1* 0 0
D 0 0 0 0 0 0
E 0 0 0 0 0 0
F 0 0 0 0 0 0
G 1# 1$ 1* 1* 0 0
H 1* 1* 1* 1* 1* 1*
I 1* 1* 1* 1* 0 0
J 0 0 0 0 0 0
K 0 0 1* 1* 0 0
L 0 0 0 0 0 0
M 0 0 0 0 0 0
N 0 0 0 0 0 0
O 0 0 0 0 0 0
P 0 0 0 0 0 0
Q 0 0 0 0 0 0
EDV= end-diastolic volume; ESV= end-systolic volume; LVEF= ejection fraction. COV= coefficient of variation; 
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off point for severe perfusion defects. Some studies report on mean count activity. Chua et al 
[7] presented a mean count activity of 19.9% ± 10.5 % of maximal myocardial count activity. 
Hashimoto et al [20] reported that myocardium with a per cent peak count of 40% or less 
has very low probability of myocardial viability. This is in line with our cut-off value for severe 
perfusion defect. 
Integration of results obtained per degree freedom. 
The variations in quantitative results, as found per degree freedom, were clearly not 
independent in a statistical sense. Each variation, as found, is the vector sum of multiple 
components, including the filtering [smoothing] effects of any oblique re-orientation of the 
voxel space. As the latter component is present in the results for all degrees of freedom, but 
would be encountered only once during normal operation, vector addition would overestimate 
the cumulative effects considerably. Therefore a pragmatic alternative was chosen: only the 
worst 3 degrees freedom were evaluated (for exact criteria see methods). The analysis resulted 
in a large amount of summary results that could not be presented in a meaningful manner 
without this or a similar data-reduction approach. Each individual prototype resulted in 43 
summary statistics per degree freedom evaluated, for a total of 344 standard deviations, 
which is obviously too high for practical use. It was therefore considered impractical to present 
quantitative results instead of the presented segmentwise dichotomous results. The chosen 
practical limits loosely represent 20% variation, expressed as COV (referring to a normal 
study), 1.0 mm for wall motion, or 10% for wall thickening. It must be borne in mind that 
these limits, when expressed as 95% confidence bands correspond to + 40%, + 2.0 mm or + 
20% segmental variation respectively and hence cannot be considered too restrictive. This is 
in line with literature [22].
Figure 4. Summary Bull’s eye of the different degree of freedom..
From problematic area 
per degree freedom to 
cumulative view38
Practical implications and guidelines. 
This study was designed to identify the limits of the reproducibility of the QGS system. It also 
gives an indication of the intra-operator variability for different kinds of perfusion defects. 
Figure 3 summarizes the robustness of the QGS system for the different prototypes. The 
prototypes represent worse-case scenarios and show that when the number of perfusion 
defects is limited, the software has excellent reproducibility with regard to EDV, ESV, LVEF, 
wall motion and to a less extent wall thickening. This is in line with Paeng et al [23] who 
reported good reproducibility in group of 31 patients. Also, they found less concordance for 
wall thickening, especially in the septal and inferior region. 
When perfusion defect sizes are large, especially when the defects themselves are severe 
(<40% in the quantitative analysis that is part of the QGS software), wall thickening 
quantitation becomes unreliable in more than just one occasional segment, and figure 3A-Q 
should be consulted. Spurious activity in close proximity of the left ventricle can interfere with 
quantitation. The correlation between location of perfusion defects and lack of reproducibility 
is not very good. The operator dependent variation in segmental wall motion quantification 
remains < 10% in virtually all segments even in the presence of most of the major perfusion 
defects. Exceptions can be found in figure 3A-Q. Spurious activity in close proximity of the left 
ventricle can interfere with quantitation.
In this study QGS-software, version 2.0, revision A” was used. More recent versions of the 
software are available in which the algorithm has an automatic re-orientation procedure, 
leaving little room for operator intervention. Also for the later versions an evaluation like this 
study is necessary to evaluate its reproducibility in the different specific subgroups. 
Limitations of this study. 
The number of prototypes is relatively small and should be considered a compromise. In our 
series of experiments, it became obvious that precise territorial mapping for each defect type 
is not feasible and that the reported generic guidelines probably reflect the best achievable 
results. Furthermore, as no suitable gold standard exists with regard to the assessment of 
segmental wall motion and wall thickening, evaluation of systematic errors is cumbersome. 
Recent guidelines recommend to use a 17 segment model for the left ventricle [23]. Recently, 
Berman et al [21] reported on methods to convert a 20-segment scoring system to a 17-segment 
model. The 17-segment model demonstrated a trend toward fewer mildly abnormal scans 
and more normal and severely abnormal scans. In this study we used a 20 segment model. 
It has been shown that partitioning may play significant role in the reproducibility. Paeng et 
al [22] showed significant differences between the 20 segment model and repartitioning the 
myocardium in 5 regions. The absolute differences between repeated measurements of the 
20 segment model and the 5 segment model for wall motion and systolic thickening were 
0.77 ± 0.62 mm, 7.2 %± 7.2 % and 0.52 ± 0.49 mm, 4.5%±3.7% respectively. Absolute 
differences between the groups were significant (t test P<0.001). In a 17 segment model the 
absolute differences will be more close to the 20 segment model, and will probably not greatly 
influence our results. 
Conclusions
For the Cedars-Sinai’s Quantitative Gated SPECT software quantification the global parameters, 
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dependent settings than segmental measures for wall motion and wall thickening, and can be 
considered operator-independent. The quantification of wall motion and thickening are robust 
for operator dependent variation in processing. In the presence of major perfusion defects or 
significant spurious activity below the diaphragm, however, especially wall thickening becomes 
more operator dependent in some cases. 
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ABSTRACT
Background. Quantitative electrocardiogram-gated single photon emission computed 
tomography (SPECT) myocardial imaging (QGS) is a means of providing functional information 
about the left ventricle and myocardial perfusion. However, the functional information derived 
30 minutes post-stress may be different from the left ventricular (LV) function determined 
at rest. This study determined whether LV function post-stress would be different from LV 
function at rest in patients with an earlier myocardial infarction. 
Methods and Results. LV perfusion and ejection fraction (LVEF), were determined by means 
of both the rest and post-stress acquisition in 58 patients with an earlier myocardial infarction 
and in 23 patients with a low likelihood of coronary artery disease by using technetium-99m 
tetrofosmin and the QGS program. The interobserver and intraobserver variability of LVEF was 
excellent, within a margin of 2%. No significant differences in LVEF were observed between 
post-stress and rest in the 23 patients with a low likelihood of disease ($LVEF 0.04+/-3.2%, 
p = not significant). Conversely, the patients with an earlier myocardial infarction showed a 
significantly lower LVEF post-stress, compared with that at rest ($LVEF -1.9+/-4.2%, p=0.002). 
In 33 patients (57%), the LVEF post-stress was 2% or more lower than the LVEF at rest. 
Furthermore, reversible ischemia, which was present in 16 patients (28%), did not interact 
with the $LVEF post-stress, compared with the $LVEF at rest (p=not significant). Parameters 
such as the stress modality (adenosine stress or exercise), the number of stenosed vessels, or 
the perfusion defect severity score did not influence the $LVEF post-stress, compared to $LVEF 
at rest. 
Conclusions. In patients with an earlier myocardial infarction, LV function post-stress may 
not represent true resting LV function. Consequently, this result justifies the stratification of 
patients before starting the gated SPECT study. In patients with an earlier myocardial infarction, 
the gated acquisition should be performed during the rest study. 
INTRODUCTION
Bacause left ventricular ejection fraction (LVEF) is a major determinant of prognosis in patients 
with coronary artery disease, it is important to assess LVEF in addition to myocardial perfusion 
[1]. The recently developed quantitative gated single photon emission computed tomography 
(SPECT) program (QGS) provides reliable information on LVEF, LV wall thickening, LV wall 
motion, LV end-diastolic volume (LVEDV) and LV end-systolic volume (LVESV) in addition to 
myocardial perfusion [2-4]. Gated acquisition of the stress myocardial perfusion images 30 
minutes post-stress is generally considered myocardial perfusion at maximal stress where LV 
function is the resting situation. However, post-stress LV dysfunction may develop in patients 
with stress-induced ischemia, probably because of myocardial stunning [5-8]. This implies that 
when gated SPECT is obtained 30 to 45 minutes post-stress, LVEF and LV volumes may not 
represent the true resting LV function. Furthermore, the influence on LV function obtained by 
using pharmacological stress (adenosine, dipyridamole or dobutamine), as compared with that 
obtained by using exercise stress, is not fully elucidated [9-14]. The recently developed QGS 
program is applied routinely in an increasing amount of nuclear imaging departments worldwide 
[2-4]. So far, no studies involving pretest stratification of patients have been published. The 
aim of this study was to determine whether LV function post-stress would be different from 
basal LV function at rest in patients with a previously sustained myocardial infarction and 
whether there was a different influence on LV function between pharmacological stress and 
conventional exercise stress. This information may facilitate the stratification of patients before 
they undergo a gated SPECT study. 
METHODS
Patients 
We studied 58 consecutive patients with an earlier myocardial infarction. There were 10 
women and 48 men (mean age, 61.8 ± 11.6 years; range 50 to 80 years). In all patients, a 
persistent defect in at least 3 of 18 LV segments was shown with gated SPECT myocardial 
perfusion imaging. Exclusion criteria were left bundle branch block, irregular heart rhythm, 
and reconstruction artifacts caused by tracer activity in intestines lying next to the heart. The 
baseline characteristics of the 58 patients are listed in table 1. A control group of 23 patients, 
who had a low pretest likelihood of coronary artery disease and normal results on a myocardial 
perfusion scintigram (Table 1), was selected.
Stress protocols
All patients underwent a 2-day imaging stress/rest protocol, in which the gating was done 
during both the rest and the stress myocardial perfusion SPECT acquisition. In 24 patients (41%), 
a symptom-limited exercise stress test was performed in the upright position with a bicycle 
ergometer. In all patients undergoing physical exercise, beta-blocking agents were discontinued 
at least 48 hours before the test. The exercise stress protocol included a stepwise increase in 
workload depending on gender, age, weight and height. This protocol is routinely applied in 
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and height) is achieved, the physical validity is considered to be at least 100%. Exercise stress 
endpoints were severe angina, physical exhaustion, dyspnoea, sustained tachyarrhythmias, 
exertional hypotension, or ischemic sinus tachycardia (ST)-T segment depression of at least 
0.2 mV with a duration of 80 ms. Exercise was considered inadequate when the physical 
validity of the patient was less than 80% of the predicted validity (workload) in the absence of 
angina or an ischemic ST depression. Pharmacological stress with 0.14mg/kg/min adenosine 
during 6 minutes was used in 27 patients (47%) who were not able to exercise adequately. 
All these patients withheld caffeine-containing beverages for 12 hours before the test. A dose 
of 300 µg/kg dobutamine in 15 minutes was used in 7 patients (12%) who where not able to 
exercise adequately and who also had a contraindication to the use of adenosine. Before and 
every minute during stress, 12-lead electrocardiography (ECG) was performed. In case of ST-T-
segment abnormalities, registration of the stress ECG was continued until normalization of the 
electrocardiogram was seen. 
Exercise versus pharmacological stress
To assess the influence of different stress modalities on the change in LVEF, LVEDV, and 
LVESV, we analyzed baseline and post-stress LVEF, LVEDV and LVESV both in the patients who 
received pharmacological stress agents and the patients who underwent ergometry stress. For 
the purpose of this study, we only compared adenosine stress with conventional exercise. 
Image acquisition protocol
A dose of 500 MBq (13.5mCi) technetium-99m tetrofosmin (Myoview, Cygne-Amersham) was 
administered 45 to 60 minutes before rest image acquisition and 30 minutes before to stress 
image acquisition. Imaging was performed with the patient in prone position with a Toshiba 
GC-9300 triple-head camera equipped with high-resolution collimators and connected to a 
Table 1. Patients characteristics and stress modalities used.
Myocardial infarction (N =58) Control Subjects (N=23)
Q-wave on ECG 51 n.a
Elevated enzymes (CK,CK-MB) 
with no Q-wave on ECG
7 n.a
Age (y)* 61.8 ± 11.6 (range 50-80) 58.5 ±10.4 (range 47-85)
Men* 48 13
Women 10 10
Stress modality -Ergometry 24 13
-Adenosine 27 9
-Dobutamine 7 1
1-vessel disease 17 n.a.
2-vessel disease 14 n.a.
3-vessel disease 12 n.a.
No angiogram 15 n.a.
* P <0.05 for difference in age and gender between patients and control subjects. Controls subjects 
were defined as patients with a low pre-test likelihood of coronary artery disease and normal results on a 
myocardial perfusion scintigram.  n.a.=not applicable
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Toshiba GMS 5500 computer. A 360-degree rotation with a noncircular orbit as close to the 
patient as possible was obtained with 90 steps of 4 degrees, 30 seconds per step, and a 64-by-
64 matrix size. A 20% symmetric energy window centered on the 140 keV peak was used. 
Sixteen frames per cardiac cycle were gated. The data were prefiltered with a Butterworth 
filter power 9, order 8, and a cut-off frequency of 0.32, and they were reconstructed with 
the filtered back-projected algorithm and a Ramp filter. The data were reoriented to obtain 
oblique-angle tomograms parallel to the long axis and short axis of the left ventricle. The 
reconstructed data were projected as tomographic slices in short, vertical, and horizontal axis 
views in a side-by-side display. In addition, the images were displayed as polar plots (bull’s-
eye maps). Numerical values of LV volumes and LVEF were calculated by using a commercially 
available software package (QGS), yielding a dynamic 3-dimensional LV image developed by 
Germano et al. [2-4,15,16] 
Static image analysis
On the static perfusion images, semiquantitative analysis of myocardial perfusion was 
performed for 18 LV segments. There were 6 segments on a preapical and mid-short-axis slice, 
4 segments on the basal short-axis slice, (the septal part was left out because of the presence 
of the membranous part of the interventricular septum), and 2 apical segments on the vertical 
long-axis slice. This segment scheme is a modification of the scheme used by Germano et 
al.[3]. The analysis was done in both rest and stress perfusion images. All segments were 
scored using a 4-point scale: no uptake; less than 30% of normal perfusion (score 0), severely 
diminished uptake; 30% to 55% of normal perfusion (score 1), slightly diminished uptake; 56% 
to 80% of normal perfusion (score 2); and 80% to 100% of normal perfusion (score 3), normal 
uptake. The percentages were judged by using a hot-metal square color scale. The scoring 
was done by 2 experienced observers in consensus (CB, MS). Defects were characterized as 
fixed or reversible. A defect was considered to be fixed when there was no change between 
the stress and the rest image. A defect was considered to be reversible when there was an 
improvement in tracer uptake of at least 1 grade between stress and rest images. A perfusion 
defect severity score was calculated by summing the scores of 18 segments in the rest study. 
A lower score implies a more extensive perfusion defect. The severity of the reversibility was 
judged by calculating the numerical difference in perfusion score between the rest and stress 
study. Based on the stress-rest images, patients were divided into groups: patients with only 
fixed defects (n=42) and patients with additional reversible defects (n=16). Additional ischemia 
was defined as reversible ischemia in 2 or more LV segments in addition to the fixed perfusion 
defect.
Coronary Angiography
Coronary angiography was performed according to the standard Judkins technique. An 
obstruction of 50% or more in 1 or more of the major 3 coronary arteries seen by means of a 
visual examination was considered to be significant. 
Statistical analysis 
To determine interobserver variability, 3 technicians reconstructed the raw data of 19 patients 
to analyze LVEF. The standard deviation (SD) of the LVEF was expressed in LVEF units. The 
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with an 11 day-interval between processing instances in all 19 patients. The outside limits 
for variability of the measurements were determined to be 2 SD beyond the mean value. 
Significant differences of changes in LVEF, LVESV, and LVEDV between patients with and 
without reversible ischemia was tested by using the unpaired Student’s t test. The same test 
was applied as a means of calculating the significance of differences in differences in changes 
of LVEF, LVEDV and LVESV between patients undergoing adenosine and ergometry stress. The 
paired Student t test was used as a means of calculating the significance in change between 
post-stress and rest of LVEF, LVESV, and LVEDV within patients and control subjects. Analysis 
of variance (ANOVA) was applied as a means of analyzing the influence of reversible ischemia 
on the changes in LVEF, LVESV, and LVEDV post-stress versus rest in the whole group. ANOVA 
was also used as a means of determining the influence of the amount of stenosed vessels on 
changes in LVEF, LVEDV, and LVESV post-stress versus rest. Covariance analysis was used as a 
means of adjusting the confounding effects of age and gender. Values are shown as the mean 




For the interobserver variability, a SD of the mean LVEF of 0.77% was found (range 0.5 to 1%) 
expressed in LVEF units. For the intraobserver (P.D.) variability, a SD of 0.89% was found. The 
limits for serial reproducibility of the measurements were thus determined to be 2x0.89=1.8%. 
The Bland Altman plot showed that the differences in LVEF measurements between 2 
technologists in this reproducibility study were independent of the LVEF level. Because the 
QGS only provides integer values for LVEF, we used a cutoff value of 2% to distinguish real 
LVEF changes from LVEF changes that might be caused by imperfect reproducibility. 
Control group
The resting LVEF, LVESV, and LVEDV are shown in table 2. The mean LVEF, LVESV, and LVEDV 
in the group of patients with a low likelihood of coronary artery disease were not significantly 
different between post-stress and resting condition (Table 3). 
Table 2. Rest LVEF, LVESV and LVEDV in the control group (n=23) and in 58 patients with an earlier 
myocardial infarction.
LVEF (%) LVEDV (ml) LVESV (ml)
Controls (n=23) 54.8 ± 4.5 99.7 ± 17.6 45.3 ± 10.9
All patients (n=58) 39.5 ± 12.4* 158.2 ± 57.2* 101.2 ± 54.0*
Isch + (n=16) 35.6 ± 14.8 160.3 ± 60.0 109.7 ± 60.0
Isch -  (n=42) 41.0 ± 11.2 157.4 ± 56.9 98.0 ± 51.7
LVEF: Left ventricular ejection fraction; LVEDV: left ventricular end-diastolic volume; LVESV: left ventricular 
end-systolic volume; Isch+: reversible ischemia in addition to a fixed defect; Isch-: only a fixed defect. 
Values represent mean ± SD. *p<0.001, difference in rest LVEF, LVEDV, and LVESV between controls 
subjects and patients. p= not significant between patients with and without reversible ischemia. P value 
obtained with the unpaired Student’s t test. 
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Myocardial infarction group
The mean resting LVEF, LVEDV and LVESV in patients with an earlier myocardial infarction are 
listed in Table 2. There was a significant difference in rest LVEF, LVEDV, and LVESV between the 
patient and control group (Table 2). In contrast, there were no significant differences in rest LV 
parameters between patients with and without reversible ischemia (Table 2). Within the total 
group of 58, we found a significant average change in LVEF, LVEDV and LVESV post-stress 
versus the resting condition (Table 3). Conversely, the difference in change of LVEF, LVESV and 
LVEDV between the rest and the stress acquisition was not different between patients with 
and patients without reversible ischemia [LVEF(%), 0.94 ±1.1 (p=0.5), LVEDV(ml), -4.7 ±4.6 
(p=0.4); LVESV(ml), -4.4 ±4.2 (p=0.4)]. Thus, it was demonstrated by means of ANOVA that 
the presence of reversible ischemia, which occurred in 16 patients (28%), did not influence 
the differences in LVEF, LVEDV and LVESV post-stress, as compared with the resting condition 
(p=0.4). By using the cutoff value of 2% to define a true change, we found a decrease (>2%) 
in LVEF in 33 patients (57%), an increase (>2%) in LVEF in 12 patients (22%), and no change in 
LVEF in 13 patients (21%; Figure 1). The amount and severity of the perfusion defects were not 
predictive of changes in LVEF post-stress compared with rest LVEF (r=0.05).
Table 3. Changes in LVEF, LVESV and LVEDV post-stress compared with rest in the 23 control patients 
and in patients with previous myocardial infarction. 
$LVEF (%) $LVEDV (ml) $LVESV (ml)
Control patients (n=23) 0.04 ± 3.2* -1.3 ± 7.6* -0.7 ± 5.1*
Patients with earlier MI (n=58) -1.9 ± 4.2a  7.9 ± 17.6b 6.5 ±18.7c
$: Difference post-stress compared with rest; LVEF: left ventricular ejection fraction; LVEDV: left 
ventricular end-diastolic volume; LVESV: left ventricular end-systolic volume; MI: myocardial infarction. 
Values represent mean +/- SD. *: p=not significant; Patients: a p=0.002 for $LVEF; b p= 0.001 for $ LVEDV 
and c p=0.002 for $LVESV. P values obtained with the paired Student’s t-test.
Figure 1. Percentage of patients with myocardial infarction with 1: decrease (> 2%),  2: unchanged 
(–2%<x<2%) or 3: increase (>2%) of left ventricular ejection fraction post-stress compared to rest. SEE 
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Coronary Angiography
In 43 patients (74%), coronary angiography data were available. The changes in LVEF, LVEDV, 
and LVESV post-stress between patients with 1, 2, or 3 stenosed vessels were not statistically 
significant (Table 4).
Stress modality
In the group of patients with an earlier myocardial infarction, there were no significant 
differences in resting LV function between the patients who underwent adenosine stress 
and the patients who underwent conventional exercise (Table 5). Also the changes in LVEF 
and LVESV post-stress compared with those at rest were not significantly different between 
groups. There was a marginally significant increase in LVEDV for the adenosine group (p=0.04). 
However, when applying the Bonferroni correction, the differences in change of LVEDV 
between both stress modalities were no longer statistically significant (p=0.08; Table 5). 
Table 4. Influence of the number of stenosed vessels on changes in LV functional parameters post-
stress compared with rest. In 43 of 58 patients (74%), a coronary angiogram was available.
1-vessel disease 
(n=17, LAD 12, 
RCA 4, LCX 1)
2-vessel disease 
(n= 14, LAD 12, 
RCA 6, LCX 10)
3-vessel disease 
(n=12)
P value by means 
of ANOVA
Rest LVEDV (ml) 163.1 ± 59.5 145.7 ± 62.5 173.1 ± 43.6 NS
Rest LVESV (ml) 102.3 ± 57.0 94.8 ± 58.8 114.8 ± 46.0 NS
Rest LVEF (%) 40.8 ± 13.2 39.3 ± 14.8 36 ± 11.8 NS
$LVEDV (ml) 7.5 ± 20.8 4.36 ± 14.8 5.6 ± 18.9 NS
$LVESV (ml) 8.6 ± 14.8 4.9 ± 15.5 8.25 ± 21.9 NS
$LVEF (%) -2.1 ± 3.9 -1.3 ± 3.3 -1.9 ± 5.5 NS
LAD: Left coronary artery; RCA: right coronary artery; LCX: left circumflex artery; $LVEF: change in left 
ventricular ejection fraction post-stress compared with rest; $LVEDV: change in left ventricular end-
diastolic volume post-stress compared with rest; $LVESV: change in left ventricular end-systolic volume 
post-stress compared with rest; NS: not significant. ANOVA, analysis of variance.
Table 5. Mean LV function parameters in patients with different stress modalities. Because there 
were only 7 patients with dobutamine stress, we only calculated the P values between adenosine and 
conventional exercise.
Ergometry (n=24) Adenosine (n=27) P Ergometry vs Adenosine
Rest LVEDV (ml) 169.4 ± 110.7 150.0 ± 51.6 NS
Rest LVESV (ml) 110.7 ± 57.8 92.0 ± 48.0 NS
Rest LVEF (%) 37.6 ± 11.5 41.8 ± 12.1 NS
$LVEF (%) -1.2 ± 4.6 -2.6 ± 4.2 NS
$LVEDV (ml) 1.0 ± 18.4 11.9 ± 17.9 0.04, Bonferroni: 0.08
$LVESV (ml) 4.1 ± 20.4 11.7 ± 15.6 NS
LVEDV: Rest left ventricular end-diastolic volume; LVESV: rest left ventricular end-systolic volume; LVEF: 
rest left ventricular ejection fraction; $LVEF: change in left ventricular ejection fraction post-stress 
compared to rest; $LVEDV: change in left ventricular end-diastolic volume post-stress compared to rest; 
$LVESV: change in left ventricular end-systolic volume post-stress compared to rest; NS: not significant. 
Values represent mean ± SD.
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Discussion
Gated SPECT myocardial imaging is routinely performed in many nuclear imaging departments. 
Because of logistics, the gating may be done during the acquisition of either the rest or the 
stress study. Several studies have shown a transient deterioration of LV function in patients with 
exercise-induced ischemia that persists long after cessation of exercise [5,6,8,17]. Therefore, 
when gated acquisition is only done during the acquisition of the stress perfusion study, LV 
function 30 minutes post-stress may not represent true LV function at rest. However, it is not 
known beforehand which category of patients will show reversible ischemia. Therefore, it is 
not possible to decide ahead of time whether the gated acquisition has to be done at rest. In 
our study, taking into concern the interobserver and intraobserver variability, we calculated a 
decrease of 2 or more LVEF points to be significant. The average decrease in LVEF for the whole 
patient group with a myocardial infarction was 1.9%, which was statistically significant. The 
highest LVEF decrease in this study was 13%. Although an average decrease of 1.9 LVEF points 
post-stress compared with rest is not clinically important, it is not fully known which patient 
will show a clinically significant or insignificant change when the rest study is non- gated. 
In our study we found that 33 of 58 patients (57%) with a previously sustained myocardial 
infarction showed a statistically significant deterioration of LV function (>2%) that persisted 
as long as 30 minutes after stress, even in patients without concomitant reversible ischemia. 
This finding allows the stratification of patients before starting the gated SPECT study. In all 
patients with definitive evidence of a previously sustained myocardial infarction, gating should 
be performed during the acquisition of the resting study to determine the true LV function at 
rest. Subsequently, in these patients, we found a similar change of LV function between post-
stress and rest for patients who had adenosine stress and patients who underwent bicycle 
exercise.
Previous studies
Several studies have shown a transient deterioration of LV function in patients with exercise-
induced ischemia that persisted long after cessation of exercise [5,6,8,17,18]. This phenomenon 
may be attributed to myocardial stunning, which has been defined as spontaneous reversible 
post-ischemic dysfunction in the presence of normalized perfusion [19]. This implies that patients 
with ischemia shown by means of the perfusion image may have a decreased LV function 
when gating is done during the post-stress study. Several pathophysiological mechanisms of 
myocardial stunning have been put forward, such as the oxygen-radical hypothesis and the 
calcium-overload hypothesis [19-22]. 
To date, only a few articles have been published on the evaluation of LV function at least 
30 minutes post-stress analyzed with 99mTc labeled agents in combination with the QGS 
program [7,17,18]. Johnson et al.[7] analyzed 22 patients in whom a significant decrease in 
LVEF post-stress was shown. All 22 patients had reversible ischemia, and 10 of the patients 
(50%) had a history of myocardial infarction. In another group of patients (n=20), in whom 
only a fixed defect was shown, the average change in LVEF post-stress was not significant. In 
this group, 14 patients (70%) had sustained an earlier myocardial infarction. Because 6 of the 
patients (30%) were not known to have an earlier myocardial infarction, these results are not 
comparable with our results. Our findings are discordant with the findings of Paul et al.[17] 
who could not find a deterioration in LV function in 18 patients with a myocardial infarction. 
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without additional historical or enzymatic evidence of earlier myocardial infarction. Because 
a fixed perfusion defect may be caused by an attenuation artifact, the perfusion abnormality 
might not necessarily represent infarcted tissue. In a recent study by Hashimoto et al.[18], a 
significant depression of post-stress LVEF relative to resting LVEF was shown in 11 patients 
with severe reversible ischemia. However, the authors did not explicitly describe whether their 
patient population (n=47) consisted of patients with an earlier myocardial infarction. As a 
result, it is not possible to compare their findings with ours. 
Theoretical explanation
An explanation for the prolonged dysfunction after exercise in patients with myocardial 
infarction is the relative imbalance between oxygen supply and demand. In the presence of 
a flow-limiting coronary artery stenosis, exercise results in an alteration of the transmural 
distribution of myocardial perfusion in a manner such that flow is distributed preferentially 
to the subepicardium, while the subendocardium is most severely hypoperfused [23,24]. 
Moreover, it is known that the oxygen consumption per gram of tissue is usually higher in 
the subendocardium than in the subepicardium, and transmural thickening occurs primarily 
in the endocardial layer [25]. During stress, a relative high imbalance between oxygen supply 
and demand in the subendocardial layers subtended by stenosed vessels may develop without 
significant changes in overall blood supply. This may, in turn, lead to stunning and, hence, a 
decrease in LV function without signs of reversible ischemia on the myocardial perfusion images. 
In the QGS software program, an asymmetric Gaussian is fitted to each profile, and the inner 
and outer standard deviations of the Gaussian are noted [2]. A thinner perfused myocardium 
would decrease the count activity in the myocardial wall (partial volume effect), but probably 
would not shrink the width of the Gaussian count distribution across the wall much. Thus, in 
our opinion, a technical factor such as endocardial count loss is not an explanation for the fall 
in LVEF post-stress. Another factor leading to a relative high need for oxygen is the higher 
wall stress which occurs in large ventricles subjected to a previous myocardial infarction. This 
high oxygen need is further augmented during stress. When the blood supply is not adequate, 
this may also result in a relative deprivation of oxygen and, hence, may lead to myocardial 
stunning. 
It is known that neurons are more sensitive to ischemia than myocytes. Therefore, LV 
dysfunction post-stress leading to a fall in LVEF could also be caused by neuronal dysfunction 
that is exaggerated during stress because of ischemia [26-28]. Because imaging with iodine-
123-metaiodobenzylguanidine (a radio labeled norepinephrine analogue reflecting cardiac 
sympathetic activity) was not performed in our studied population, this neuronal involvement 
is only hypothetical. 
Influence of the amount of stenosed vessels
We found no statistically significant differences between patients with 1-vessel, 2-vessel or 
3-vessel coronary artery disease in the post-stress changes in LV function. This implies that 
there is probably no linear relationship between the extent of stenosed vessels and the 
level of LV function 30 minutes post-stress. The infracted myocardium is probably the major 
determinant of global LV function. Although the number of patients in the 3 groups was not 
high (n=17, n=14,n=12) our findings were confirmed by Johnson et al.[7] who found that the 
number of diseased vessels was not a dependent variable that correlated significantly with LVEF 
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changes. In addition, Marcassa et al.[29] found that the extent of coronary artery disease was 
similar among patients with and without transient LV dilatation post-stress. Conversely, several 
studies have reported that the degree of LV dysfunction is related to angiographically assessed 
severity of coronary artery disease [12,13]. However, these studies are not comparable with 
our study, because dypiridamole radionuclide angiography was used as a means of assessing 
LV function, and thallium-201 dipyridamole images were used as a means of measuring the 
LV cavity. In addition, functional information was obtained during stress and not 30 minutes 
post-stress [12,13]. 
Influence of the severity of the perfusion defect
There was no significant correlation between the severity of the fixed perfusion defects and 
the change of LVEF post-stress, compared with rest. This could be explained by the extent of 
damaged neurons, which exceeds the extent of tissue necrosis defined by means of rest blood 
flow abnormalities. Because neurons are more sensitive to ischemia than myocytes [26-28], 
we tentatively conclude that the damaged tissue may be more extensive than one would judge 
from the number of perfusion defects. 
Influence of stress modality on post-stress LV function
In our group, 47% of the patients had adenosine as stress modality, 41% of the patients had 
ergometry, and 12% of the patients had dobutamine. The resting LV functional parameters 
and the change in LVEF and LVESV post-stress were not different between the patients who 
had adenosine stress and the patients who underwent conventional exercise. In the adenosine 
group, there was a marginally significant higher difference in change in EDV post-stress, 
compared with rest. However, when we applied the Bonferroni correction, this significance 
did not hold. Moreover, because the number of patients in the subgroups (adenosine, n=27; 
conventional exercise, n=24) was relative low, we think it is preferable to conclude that there 
was a trend towards a higher change in LVEDV in the adenosine group than that in the 
conventional exercise and not a significant difference in increase of LVEDV between both 
stress modalities. In accordance with our study, Nallamothu et al.[30] found more patients 
with LV cavity dilatation in the adenosine group than patient who underwent bicycle exercise, 
although no explanation was provided. Several studies reported a significant increase in 
pulmonary capillary wedge pressure in patients with coronary artery disease, compared with 
healthy subjects, when adenosine was used [11,31,32]. The increase in pulmonary wedge 
pressure is probably initiated by a change in vascular loading, higher LVED pressure, or diastolic 
dysfunction, which in turn leads to a higher EDV. In our opinion, it is not unlikely that this 
phenomenon may persist long after cessation of the infusion.
Controversial opinions exist about the influence of adenosine or dipyridamole on LV function 
[9,13,29]. Pennell et al.[9] found that the site of wall motion deterioration found by using 
magnetic resonance imaging was always the site of a reversible thallium-201 defect. In a later 
study analyzing the influence of dobutamine on LV function by using magnetic resonance 
imaging, Pennell et al.[10] suggested that dobutamine is more effective in eliciting wall motion 
abnormalities in patients with coronary artery disease than dipyridamole. Ogilby et al.[11], who 
used adenosine in patients with coronary artery disease, observed perfusion defects without 
a decrease in global and regional systolic function. Conversely, the authors found a higher 
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Takeishi et al.[12] stated that dilatation of the LV cavity on dipyridamole Tl-201 imaging 
reflected relative subendocardial hypoperfusion induced by dipyridamole, rather than actual 
chamber enlargement. The cavity area increased, but the ventricular area did not change. 
In contrast, Klein et al.[13] concluded that dipyridamole induces ischemia that is sufficiently 
significant to be detected by means of radionuclide ventriculography such as LV dilatation 
and dysfunction. Marcassa et al.[29], who studied 234 patients, 130 of whom sustained a 
previous myocardial infarction, reported a similar incidence of transient LV dilatation after 
exercise and during pharmacologic stress testing (37% and 36%, respectively). However, the 
authors found LV dilatation in 86 patients (37%) of whom only 19 (22%) showed epicardial 
transient dilation. The remaining 67 patients showed endocardial transient dilation without 
concomitant epicardial dilation, probably caused by diffuse subendocardial hypoperfusion 
simulating an increase in LV cavity dimension. None of these studies used a QGS program 
similar to that applied in the present study, which could lead to different results. 
Study limitations
Johnson et al.[7] analyzed the reproducibility of the test by applying the same gated SPECT 
approach as used in this study in 15 patients 24 hours later. They found a reproducibility of 
5.2%. Because it was not allowed because of ethics in our institution to repeat the total 
myocardial perfusion test 1 day later, we tested the reproducibility of LVEF measurements by 
analyzing the interobserver and intraobserver variability by reconstructing the raw data. The 
reproducibility showed a mean standard deviation of 0.89%. Patients were studied in prone 
position during the acquisition of both the rest and stress study, eliminating the variability 
of LVEF caused by a difference in positioning [33]. In our study, only patient studies without 
gating problems or acquisition problems were used. Furthermore, the same technologist 
reconstructed the acquisition data for the rest and the stress study in 1 patient according to a 
standard protocol. Although a circumstantial variation cannot be excluded, we do not assume 
that the reproducibility would have been less accurate. 
CONCLUSIONS
Most patients with an earlier myocardial infarction who undergo gated SPECT show a 
significant decrease in LVEF lasting at least until 30 minutes post-stress. This phenomenon 
occurs irrespective of the presence of demonstrable reversible ischemia or the stress modality 
used. To obtain true LVEF and LV volumes at rest in patients with an earlier myocardial 
infarction, it is preferable to perform the gating during the rest acquisition. 
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Prognostic value of gated SPECT 
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ABSTRACT
Background. The aim of this study was to assess the prognostic value of technetium-99m 
tetrofosmin gated SPECT imaging in patients with left bundle branch block (LBBB) using 
quantitative gated single photon emission computed tomography (SPECT) imaging.
Methods and Results. We followed 101 consecutive patients with LBBB using technetium-
99m tetrofosmin gated SPECT imaging. Average follow-up was 1.24 years (max. 2.48). Hard 
endpoints were all-cause death and acute myocardial infarction. Event-free survival curves 
were obtained. Optimal cut-off points for LV volumes and LVEF to predict outcome were 
determined by ROC curve analysis. Of the patients, 94 had an abnormal study. Fifteen hard 
events occurred (13 deaths). Perfusion abnormalities were similar for patients with or without 
events. For LV function parameters the survival curves were maximally separated when we 
used cutoff values of 160 ml or greater for end-diastolic volume (p=0.019 and hazard ratio 
[HR] of 1.04 for hard events, p=0.024 and HR 1.04 for all-cause death), 100 ml or greater for 
end-systolic volume (p=0.043 and HR of 1.04 for hard events, p=0.062 and HR of 1.04 for all-
cause death), and lower than 35% for LVEF ( p=0.013 and HR of 0.81 for hard events, p=0.047 
and HR of 0.81 for all-cause death).
Conclusion. By use of quantitative gated SPECT imaging, LBBB patients with an end-diastolic 
volume of 160 ml or greater, end-systolic volume of 100 ml or greater, or LVEF lower than 35% 




A left bundle branch block (LBBB) pattern on the electrocardiogram (ECG) severely reduces the 
diagnostic accuracy of treadmill or bicycle exercise testing for the detection of coronary artery 
disease (CAD) [1-3]. Myocardial perfusion scintigraphy has a high sensitivity but decreased 
specificity for detecting ischemic heart disease in patients with LBBB [1,3,4]. The addition of 
regional left ventricular (LV) function parameters by gated SPECT improved the diagnostic 
accuracy and prognostic value of perfusion imaging, whereby LV function parameters have 
incremental prognostic value over perfusion data alone [5-11]. 
At present, few data exist on the prognostic value of gated SPECT in patients with LBBB. In 
this category of patients, no data are available on the value of LV function parameters to 
potentially improve risk stratification. Accordingly, the aim of the study was to assess the 




 We studied 101 consecutive patients (67% men, mean age 65±8.4 years) with known LBBB 
who underwent rest/stress technetium-99m tetrofosmin myocardial perfusion gated SPECT 
imaging between October 1, 1999, and January 1, 2002 at the Leiden University Medical Center 
were included. Patients were followed up until the fixed census date April 1, 2002. Patients 
with known non-ischemic dilated cardiomyopathy or valvular heart disease were excluded. 
According to the WHO/ ISFC definition, non ischemic dilated cardiomyopathy was defined 
as dilatation and impaired contraction of the left ventricle (or both ventricles) not associated 
with cardiovascular disease in which the degree of myocardial dysfunction is explained by the 
extent of ischemic damage [12]. Dilated cardiomyopathy was defined as: 1. a LVEF less than 
45% and/or fractional shortening less than 25%, as ascertained by echocardiography. 2. a left 
ventricular end-diastolic diameter greater than 117% of the predicted value of corrected for 
age and body surface area [13].
Stress Myocardial Perfusion Protocol
All patients were instructed to refrain from caffeine-containing products for 24 hours before 
the test. Beta-blocking agents were discontinued at least 48 hours prior to SPECT imaging. All 
patients underwent a pharmacological stress test as described previously [14]. Vasodilatation 
was induced using intravenous administration of adenosine at a dose rate of 0.14 mg/kg/min 
for 6 minutes. Technetium-99m tetrofosmin (GE, Amersham, UK) was injected 4 minutes after 
start of infusion of the pharmacological agent. 
Gated SPECT Acquisition Protocol
Both 1-day and 2-day imaging protocols were used [14]. A dose of 500 MBq technetium-99m 
tetrofosmin was given intravenously for the 2-day protocol stress study and 750 MBq for the 
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rest study. All acquisitions took place 30-45 minutes (stress) or 45-60 minutes (rest) post-
injection. Gating was performed under resting conditions during the myocardial perfusion 
SPECT acquisition following either the rest study (in the 2-day protocol) or the stress study (in 
the 1-day protocol). Imaging was performed with a triple-head 360° rotating gamma camera 
(Toshiba GC-9300 GMS, Japan). A total of 90 frames of 30» duration using a 64 x 64 pixel 
matrix were obtained at 4-degree intervals using a non-circular orbit. Sixteen bins per cardiac 
cycle were acquired. All studies were pre-filtered using a 9-order Butterworth filter at a cut-off 
frequency of 0.32 cycles/pixel (rest) [pixel size 6 mm] or 0.26 cycles/pixel (stress). All images 
were subject to quality control measures, including cinematic display for assessment of patient 
motion, corrections for field non-uniformity and center of rotation. No attenuation or scatter 
correction was used. The reconstructed data were projected as tomographic slices in short-
axis and vertical/horizontal long-axis views. Myocardial perfusion data and quantitative LV 
volumes and LVEF were calculated using the commercially available Cedars-Sinai’s Quantitative 
gated SPECT (QGS) software, version 2.0, revision A” [6,7]. When automatic reconstruction or 
reorientation failed, reconstruction limits and axes were assigned manually. 
Semi-quantitative Visual Analysis of Myocardial Perfusion SPECT
Semi-quantitative visual interpretation of SPECT perfusion images used short-axis and vertical 
long-axis tomograms divided into 20 segments for each patient [15]. These segments were 
assigned to 6 evenly spaced regions in apical, mid-ventricular and basal slices of the short-axis 
views and two apical segments on the mid-ventricular vertical long-axis slice. Each segment 
was scored using a five-point scoring system (0=normal, 1= equivocal, 2=moderate, 3= severe 
reduction of radioisotope uptake, 4= absence of detectable radiotracer in a segment). Apparent 
perfusion defects presumably caused by soft tissue attenuation were assigned a score of 1. 
The observers were blinded to the patient’s clinical history and results of stress testing. 
Three global perfusion indices were employed to combine assessments of defect extent 
and severity [15]. A summed stress score (SSS) was obtained by adding the scores of the 20 
segments of the stress perfusion images. A summed rest score (SRS) was obtained by adding 
the scores of the 20 segments of the rest perfusion images. The sum of differences between 
the stress and rest scores of each of the 20 segments was defined as the summed difference 
score (SDS) or reversibility score. All studies were evaluated by at 2 experienced observers in 
consensus readings. A perfusion study was considered normal when the SSS was % 4 [16].
Patient Follow-up
Both medical records and the automated hospital information system were reviewed. If these 
data did not cover the entire period from recruitment until census date, the patient was sent a 
questionnaire. In case of no response, a second questionnaire was sent after 3 months. All cause 
mortality was noted; in addition hard events were defined as death to all causes (confirmed 
by certificate and hospital chart of physician’s records) or nonfatal myocardial infarction. An 
acute myocardial infarction was documented by appropriate ECG findings (primary ST change: 
ST segment elevation of #1 mm in any leads concordant with [i.e., in the same direction as] 
the QRS complex; ST-segment depression of # 1 mm in any lead from V1 toV3; or ST segment 
elevation of > 5 mm in leads discordant with QRS complex [or any combination thereof]) 
accompanied by serum cardiac enzyme level changes or isolated cardiac enzyme level changes 
[17]. The cardiac enzymes levels tested were creatine kinase en troponin T. 
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Statistical Analysis
Continuous data were expressed as mean ± SD; differences in these variables between 
subgroups of patients were evaluated using unpaired Student t tests. Dichotomous data are 
presented as numbers and percentages, and differences between patient subgroups were 
evaluated by Chi-square tests or Fisher’s exact tests, as appropriate.
We applied ROC curve analyses to determine the optimal cut-off values for LV volumes and 
LV ejection fraction to predict events during follow-up. Optimal cut-off values were defined as 
values resulting in the maximal sum of sensitivity and specificity. Event-free survival curves were 
obtained according to the method of Kaplan and Meier. Differences in event-free survival between 
patients at suspected low versus high risk (applying the cut-off value) were evaluated by log-rank 
tests. Univariable Cox proportional hazard regression analysis was used to further explore the 
relation between perfusion and functional data and the incidence of cardiac endpoints over 
time. We report hazard ratios and corresponding 95% confidence intervals (CI). 
Annual event rates were calculated as the number of events divided by the sum of each 
individual follow-up period in years. For all analyses, a p value <0.05 was considered 




The patients’ baseline characteristics are shown in Table 1. Of the patients, 68 patients 
were male (67%). The mean age was 65.0 + 8.4 (range 44 -84 years). Of those, 74 (73%) 
patients had known coronary artery disease. Of those, 48 (47.5%) had sustained a myocardial 
infarction, 23 (22.7%) had undergone 1 or more revascularization procedures, and 10 (9.9%) 
had a history of cardiac arrest.
Perfusion and Function
Of the patients, 93% of the patients had an abnormal perfusion study. The average SSS was 
34.4 ± 17.5 (range 0-67), the mean SRS was 33.1 ± 16.9 (range 0-65), and the mean SDS 3.7 ± 
5.6 (range 0-34). Mean EDV was 194.2 ± 111.2 ml (range 55-657 ml), mean ESV 137.7 ± 106.4 
ml (range 14-603 ml), and LVEF 36.9 ± 17.9 % (range 8-75%). Of note, in patients with EF % 35 
% ( n= 51) the summed stress score ( 43.3± 15.7) and the summed rest score (40.9±16.3) were 
significantly higher than those in the total patient group (p< 0.001). Also the left ventricular 
volumes (EDV 260± 104.5 ml, ESV 203.9±98.8) were significantly larger (p< 0.001). 
Outcome 
In 93 patients (94.9%) follow-up was complete until census or death. The average follow-
up for survivors was 1.24 years (maximum 2.48 years). Thirteen patients died (all of cardiac 
causes) during follow-up, on average after 0.72 years (range 3 days - 1.37 years). One patient 
experienced an acute myocardial infarction at 359 days and one patient needed cardiac 
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Nine soft events were recorded: 5 patients underwent coronary bypass surgery on day 64, 
154, 274 and 278, and in 4 patients PTCA was performed on day 14, 59, 75 and 266 days 
after the SPECT imaging study. 
Patients with hard events were significantly older (63.9 ± 8.4 years vs 71.3±5.1 years p<0.001). 
The other baseline characteristics were not different between the 2 groups. Perfusion data 
was not significantly different between those patients with and those without hard events. 
The LV function data showed that patients with hard events had significantly larger LV volumes 
(EDV 185.1±109.2 ml vs 267.0±110.9 p= 0.021, ESV 129.0±104.0 vs 204.2±112.9 p=0.023) 
and lower LVEF (38.6±18.2 vs 26.8±12.1, p<0.001) as compared to patients with an event-free 
follow-up. 
Table 1.  Patient characteristics.
Total number of patients 101
Gender (M/F) 68/33
Age (yrs) 65.0 ± 8.4 
Risk factors for CAD





Body Mass Index 24.1 ± 2.8
Body Mass Area (m2) 1.9 ± 0.2
History




Cardiac resuscitation 10 (10%)
ICD   3 (3%)
Pharmaceuticals therapy
ß- blockers 46 (46%)
Nitrates 51 (50%)
Ca- channel blockers 30 (30%)
ACE inhibitors 52 (52%)
Platelet aggregation inhibitors 32 (32%)
Statines 61 (60%)
Antithrombin 38 (38%)
Anti-arrhythmic therapy 24 (24%)
Digitalis 17 (17%)
Diuretics 42 (42%)
CABG: coronary artery bypass graft surgery; CAD: coronary artery disease; ICD: internal cardiac defibrillator; 
PCI: percutaneous coronary intervention. Body Mass Index according to the Mosteller Formula.
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Survival
Results on the univariate analyses are listed in Table 2. ROC curve analysis was used to 
determine the optimal cut-off values for LV volumes and LVEF to predict outcome. Optimal 
cut-off values for these different parameters could be determined (LVEF 35% [sens 83%, spec. 
53%, area under the curve {AUC} 0.67], EDV 160 ml [sens 83%, spec. 52% AUC 0.73] and 
Table 2. Univariate  analysis of the gated SPECT data to predict outcome.
hazard ratio 95% CI p-value
total mortality:
EDV (ml) 1.04 1.01-1.08 0.02
ESV (ml) 1.04 1.01-1.08 0.03
LVEF (%) 0.81 0.66-1.01 0.06
SSS 1.01 0.97-1.05 0.67
SRS 1.02 0.98-1.06 0.32
SDS 0.93 0.80-1.08 0.36
hard events:
EDV (ml) 1.04 1.04-1.00 0.03
ESV (ml) 1.04 1.00-1.08 0.04
LVEF (%) 0.81 0.66-0.99 0.04
SSS 1.00 0.97-1.04 0.92
SRS 1.01 0.98-1.05 0.51
SDS 0.92 0.79-1.08 0.31
Hard events = myocardial infarction, cardiac arrest, ventricular fibrillation and total mortality. EDV = end-
diastolic volume; ESV = end-systolic volume; LVEF = left ventricular ejection fraction; SSS = summed stress 
score; SRS = summed rest score; SDS = summed difference score; CAD = coronary artery disease; CI = 
confidence interval
Figure 1. All cause mortality and hard endpoints according to the cut-off values for EDV. 
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ESV 100 ml [sens 75%, spec. 54%, AUC 0.74]). According to these cut-off values, patients 
could be divided into 2 groups (Figure 1-3). An EDV >160 ml was associated with a significantly 
higher risk of hard events (all cause death p=0.024, hard endpoint p=0.019). Patient with an 
EDV #160 ml had an annual hard event rate of 20% (13/64), whereas those with an EDV <160 
ml had an annual hard event rate of 4.8 % (3/62) (p=0.01). For ESV, maximal separation could 
be found using a cut-off volume of 100 ml (p=0.043). The annual hard event rate for patients 
with an ESV #100 ml was 19.7% (12/61), whereas those with an ESV <100 ml had an annual 
hard event rate of 6.2% (4/64) (p=0.025). No significant differences in all cause mortality were 
observed between both groups. For LVEF, maximal separation was obtained using a cut-off 
value of 35% for both all cause mortality and hard events (p=0.047 and p=0.013 respectively). 
The annual hard event rates for patients with LVEF #35% and patients with a LVEF <35% were 
19.4% (13/67) and 3.4% (2/58) respectively.
Figure 2. All cause mortality and hard endpoints according to the cut-off values for ESV. 
ESV= end-systolic volume * hard events log-rank P value = 0.043 ** all cause mortality log-rank  P value 
= 0.062
DISCUSSION
Our results show that LV volumes (ESV, EDV) and LVEF obtained by quantitative gated SPECT 
imaging have significant prognostic value in patients with LBBB. Using LV volumes and LVEF, 
patients with LBBB with increased risk of having subsequent serious cardiac events could be 
identified. Using ROC curve analysis, cut-off values for EDV of 160 ml for ESV of 100 ml 
and for LVEF 35% yielded the highest sensitivity/specificity (discriminative power) to predict 
increased cardiac risk. An EDV#160 ml and an ESV#100 ml or a LVEF of <35% were predictive 
for subsequent cardiac death. Presence or absence of myocardial perfusion abnormalities did 
not have any predictive power in our group of LBBB patients.
Prognostic Value of Perfusion Data
Our perfusion data extend previous findings that average defect size was largest in those 
patients who suffered a hard event [14,15,18]. In particular the summed stress score has 
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been shown to be a powerful independent predictor of cardiac events [19] However, these 
observations have been made in a wide spectrum of patients with suspected and known CAD, 
whereas our population was confined to patients with LBBB. In our well-defined LBBB patients 
we could not find an independent prognostic value for the perfusion data alone. 
Bavelaar-Croon et al. [20] showed perfusion abnormalities in 37 LBBB patients both in the septal 
region as well as in other areas. These authors also showed that the severity of impaired septal 
perfusion was not directly associated with the severity of septal wall motion abnormalities and 
global LV function. Altehoefer et al. [21] found fixed defects outside the septal region in 7 of 
22 patients with LBBB. 
To summarize, although we found larger perfusion defects in patients with hard events, our 
perfusion indices (summed stress score, summed rest score, and summed difference score), 
did not allow adequate risk stratification in our population of LBBB patients. 
Prognostic Value of Functional Data
To the best of our knowledge, this is the first study that addresses the added prognostic 
value of LV function data obtained from technetium-99m tetrofosmin gated SPECT in patients 
with LBBB. We found that patients who died during follow-up had significantly increased LV 
volumes and a significantly lower LVEF. LBBB patients with an EDV #160 ml or an ESV #100 ml 
or a LVEF <35% were at increased risk of subsequent cardiac events. 
Our results underscore previously published data on the prognostic value of gated SPECT 
imaging [22-26]. Sharir et al. [22] showed that perfusion variables and ESV were powerful 
markers in the prediction of total coronary events, whereas in the prediction of cardiac 
death, post-stress LVEF and ESV were independent predictors and had incremental value over 
perfusion data. According to their criteria, patients were at increased cardiac risk when they 
had a LVEF of less than 45% and an ESV greater than 70 ml. The study by Sharir et al [22] was 
performed in a very large cohort of 3200 patients, representing a heterogeneous population 
of patients with CAD in terms of LV function abnormalities. In our LBBB patients there was a 
large percentage of patients with known CAD and a history of sustained myocardial infarction. 
These differences might explain the finding of large fixed perfusion defects. These differences 
might also explain the increased LV volumes and a lower LVEF as cut-off points. Indirect 
evidence by others confirms the use of higher cut-off values in patients with LBBB. Bavelaar-
Croon et al. [20] found that patients with LBBB without previous myocardial infarction had 
a significantly decreased LV function and increased LV volumes compared to those without 
LBBB. Compared to the data reported by Sharir et al. [22], the annual event rate in our group 
of LBBB patients with an EDV #160 ml or ESV #100 ml was similar to the annual event rate of 
a mixed population of patients with an ESV >70 ml.
Study Limitations
Recent guidelines recommend a 17-segment model for analyzing the left ventricle [27]. In 
our study we used a 20-segment model. Paeng et al. [28] showed significant differences 
between the 20-segment model and repartitioning the myocardium in 5 regions. The absolute 
differences between repeated measurements of the 20-segment model and the 5-segment 
model for wall motion and systolic thickening were 0.77 ± 0.62 mm, 7.2 %± 7.2 %, and 0.52 ± 
0.49 mm, 4.5%±3.7%, respectively. Absolute differences between the groups were significant 
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to the 20-segment model, and the use of 20-segment model will probably not have influenced 
our results.
In our study perfusion data did not predict events, but the study population was relatively 
small, the follow-up period was rather short, and the number of events was low. In addition 
to these factors, most patients predominantly had large fixed defects. In addition, one should 
realize that patients with LBBB and large defects are at high risk for events because even their 
low risk group is at high risk. The results of our patient group are in line with the results of 
the group described by Nallamothu et al [24], showing increased risk for patients with larger 
perfusion defects. In this group of patients risk stratification could be further done be using 
the functional data.
In our follow-up period (1.24 years), the prognosis is mainly determined by LV size and 
function. 
CONCLUSION
In patients with LBBB, functional parameters derived from quantitative gated technetium-99m 
tetrofosmin SPECT imaging can adequately be used for cardiac risk assessment. By use of 
quantitative gated SPECT, LBBB patients with an EDV of 160 ml or greater, an ESV of 100 ml or 
greater, or a LVEF lower than 35% are at increased risk for subsequent cardiac events. 
Figure 3. All cause mortality and hard endpoints according to the cut-off values for LVEF. 
LVEF= left ventricular ejection fraction * hard events log-rank P value = 0.013 ** all cause mortality log-
rank P value = 0.047
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ABSTRACT
Background. The aim of this study was to assess the prognostic value of technetium-99m 
tetrofosmin gated SPECT imaging in women using quantitative gated single photon emission 
computed tomography (SPECT) imaging.
Methods. We followed 453 consecutive female patients. Average follow-up was 1.33 years 
(max. 2.55). Hard endpoints were cardiac death, acute myocardial infarction or documented 
ventricular fibrillation. Event-free survival curves were obtained. Optimal cut-off values for left 
ventricular (LV) volumes, LV ejection fraction (LVEF) and perfusion data to predict outcome 
were determined by ROC curve analysis. 
Results. A total of 236 patients had an abnormal study, of whom 27 patients experienced 
hard events (16 deaths) and 47 patients soft events. For hard events summed stress score (SSS) 
and LVEF, and for any cardiac event SSS showed independent incremental prognostic value. 
The survival curves were maximally separated when using cut-off values for SSS of # 22 and 
LVEF < 52% (p<0.001, HR 4.61 and p<0.001 HR 5.24 for SSS and LVEF resp.), and SSS # 14 (p< 
0.001 HR 3.76) for any cardiac event.
Conclusion. In women, perfusion and functional parameters derived from quantitative 
gated technetium-99m tetrofosmin SPECT imaging can adequately be used for cardiac risk 
assessment. Using quantitative gated SPECT, female patients with an LVEF < 52% or an SSS 
#22 are at increased risk for subsequent hard events. Furthermore, patients with a SSS#14 are 
at increased risk for any cardiac events.
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INTRODUCTION
Coronary artery disease (CAD) is the major cause of morbidity and mortality in the western 
countries. Increased mortality and reinfarction have been noted in women after myocardial 
infarction compared to men [1-3]. The large proportion of atypical symptoms, higher incidence 
of associated disease (e.g. hypertension, diabetes mellitus) and the higher age at presentation 
may account for the worse outcome [3,4]. Appropriate non-invasive diagnostic testing is 
important in the early diagnosis and the risk stratification of women with suspected CAD. 
Exercise ECG has a lower diagnostic and prognostic accuracy in women. It is influenced 
by multiple factors, i.e. exercise capacity and hormonal status [4,5]. The increased age at 
presentation is often associated with lower exercise capacity and an inability to attain maximal 
stress [4,5]. Myocardial perfusion imaging provides incremental prognostic information [4]. 
The addition of regional left ventricular (LV) function parameters by gated single photon 
emission computed tomography (SPECT) improved the diagnostic accuracy and prognostic 
value of perfusion imaging, whereby LV function parameters have incremental prognostic value 
over perfusion data alone [6-10]. Previous studies set normal functional data limits. However, 
some problems still have to be solved. First, most data on prognostic value of the parameters 
assessed by gated SPECT have been obtained in a mixed gender population and may not 
be applicable to women. Women often have smaller LV volumes. It has been shown that 
gender related differences in normal limits exist [11,12]. However, a multicenter phantom study 
showed a wide range of results in different standard end-systolic and end-diastolic volume 
combinations. Moreover, the LV ejection fraction (LVEF) was overestimated and both the end-
systolic volume (ESV) and end-diastolic volume (EDV) were underestimated. Especially, this is 
the case for small volumes. Cutoff values for LV functional parameters should be validated in 
each center [13]. 
Second, most data on prognostic value of perfusion analyses by gated SPECT is obtained 
by a 20-segment model. However, recent guidelines on cardiac imaging suggest the use of 
a 17-segment model. Berman et al [14] showed that a 17-segment model provides a more 
accurate prognostic categorization of individual patients with small abnormalities of the distal 
short axil and apical portions of the LV. 
At present, few data exist on the prognostic value of gated SPECT in women. In this category 
of patients, little data is available on the value of LV function parameters to potentially improve 
risk stratification. Accordingly, the aim of the study was to assess the incremental prognostic 
value of technetium-99m tetrofosmin (Tc99m) gated SPECT imaging in women. 
METHODS
Study Population
 We studied 453 consecutive women (median age 62 years [53-70 years, 25th-75th percentiles]) 
who underwent rest/stress technetium-99m tetrofosmin myocardial perfusion gated SPECT 
imaging between October 1, 1999, and January 1, 2000 at the Leiden University Medical 
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Stress Myocardial Perfusion Protocol
All patients were instructed to refrain from caffeine-containing products for 24 hours before 
the test. Beta-blocking agents, nitrates, calcium antagonists were discontinued at least 48 
hours prior to SPECT imaging. A symptom-limited bicycle exercise stress test was performed. 
Technetium-99m tetrofosmin (GE, Amersham, UK) was injected at peak stress, and exercise 
was continued for an additional 60 seconds. The exercise stress protocol includes a stepwise 
increase in workload depending on gender, age, weight and height. This protocol is routinely 
applied in our institution. When the prespecified maximum workload (depending on gender, 
age, weight and height) is achieved, the physical validity is considered to be at least 100%. 
Exercise stress endpoints were severe angina, physical exhaustion, dyspnoea, sustained tachy-
arrhythmias, exertional hypotension or ischemic ST-T segment-depression of at least 0.2 mV and 
a duration of 80 ms. Exercise was considered inadequate if the physical validity of the patient 
was less than 80% of the predicted validity (workload) in the absence of angina or an ischemic 
ST-depression. Patients who were unable to perform a physical stress test or patients with a 
left bundle branch block underwent a pharmacological stress test as described previously [15]. 
Vasodilatation was induced using intravenous administration of adenosine at a dose rate of 0.14 
mg/kg/min for 6 minutes. Technetium-99m tetrofosmin was injected 3 minutes after start of 
infusion of the pharmacological agent. Dobutamine 0.3mg/kg infusion during 15 minutes was 
used in patients who where not able to exercise adequately and in whom the use of adenosine 
was contraindicated (except patients with LBBB). Horizontal or downsloping ST-segment 
depression of 1 mm or greater or upsloping of 1.5 mm or greater at 80 milliseconds after J 
point was considered positive for ischemia. In case of ST-T-segment abnormalities, registration 
of the stress ECG was continued until normalization of the ECG was seen. 
Gated SPECT Acquisition Protocol
Both 1-day and 2-day imaging protocols were used [15]. A dose of 500 MBq technetium-99m 
tetrofosmin was given intravenously for the 2-day protocol stress study and 750 MBq for the 
1-day protocol stress study. Dosages of 500 and 250 MBq, respectively, were given for the rest 
study. All acquisitions took place 30-45 minutes (stress) or 45-60 minutes (rest) post-injection. 
Gated SPECT acquisition protocol was performed post-stress. In case of 1-day protocol the rest 
study was done first. Imaging was performed with a triple-head 360° rotating gamma camera 
(Toshiba GC-9300 GMS, Japan). A total of 90 frames of 30” duration using a 64 x 64 pixel 
matrix were obtained at 4-degree intervals using a non-circular orbit. Sixteen bins per cardiac 
cycle were acquired. All studies were pre-filtered using a 9-order Butterworth filter at a cut-off 
frequency of 0.32 cycles/pixel (rest) [pixel size 6 mm] or 0.26 cycles/pixel (stress). All images 
were subject to quality control measures, including cinematic display for assessment of patient 
motion, corrections for field non-uniformity and center of rotation. No attenuation or scatter 
correction was used. The reconstructed data were projected as tomographic slices in short-
axis and vertical/horizontal long-axis views. Myocardial perfusion data and quantitative LV 
volumes and LVEF were calculated using the commercially available Cedars-Sinai’s Quantitative 
gated SPECT (QGS) software, version 2.0, revision A” [7,8]. When automatic reconstruction 
or reorientation failed, reconstruction limits and axes were assigned manually. End-systolic 
volume index (ESVi) and EDV index (EDVi), in millilitres per square meter, were derived by 
dividing ESV and EDV by body surface area (BSA), respectively. 
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Semi-quantitative Visual Analysis of Myocardial Perfusion SPECT
Semi-quantitative visual interpretation of SPECT perfusion images used short-axis and vertical 
long-axis tomograms divided into 17 segments for each patient [14]. These segments were 
assigned to 4 evenly spaced regions in apical, 6 mid-ventricular and 6 basal slices of the short-
axis views and one apical segment on the mid-ventricular vertical long-axis slice. Each segment 
was scored using a five-point scoring system (0=normal, 1= equivocal, 2=moderate, 3= severe 
reduction of radioisotope uptake, 4= absence of detectable radiotracer in a segment). Apparent 
perfusion defects presumably caused by soft tissue attenuation were assigned a score of 1. 
The observers were blinded to the patient’s clinical history and results of stress testing. 
Three global perfusion indices were employed to combine assessments of defect extent and 
severity [16]. Summed stress score (SSS), summed rest score (SRS) and summed difference 
score (SDS). These indices were converted to a percentage of the total myocardium involved 
with ischemic, or fixed defects [17-18]. All studies were evaluated by at 2 experienced observers 
in consensus readings.
Patient Follow-up and Endpoint Definitions
Both medical records and the automated hospital information system were reviewed. If 
these data did not cover the entire period from recruitment until census date, the patient 
was sent a questionnaire. In case of no response, a second questionnaire was sent after 3 
months. Cardiac death (CD) was noted as death due to any cardiovascular cause, confirmed 
by certificate and hospital chart of physician’s records; in addition, hard events were defined 
as cardiac death, nonfatal myocardial infarction (MI) or documented ventricular fibrillation. 
An acute MI was documented by appropriate ECG findings, accompanied with serum cardiac 
enzyme level changes or isolated cardiac enzyme level changes. The cardiac enzymes used 
were creatine kinase (CK) en troponin T. Soft events were defined as any late (> 60 days after 
MPI) revascularization procedure i.e. coronary artery bypass grafting (CABG) or percutanous 
transluminal coronary angioplasty (PTCA). 
Statistical Analysis
Most continuous variables had non-normal distribution (as evaluated by Kolmogorov-Smirnov 
tests). For reasons of uniformity, summary statistics for all continuous variables are therefore 
presented as medians together with the 25th and 75th percentiles. Categorical data are 
summarised as frequencies and percentages. Differences in baseline characteristics between 
patients who reached the primary endpoint and those who did not were analysed using 
Wilcoxon-Mann-Whitney tests, Chi-square tests or Fisher’s exact tests, as appropriate.
Univariable and multivariable Cox proportional hazard regression analyses were applied to 
study the relation between perfusion and functional data (based on gated SPECT imaging) 
and the incidence of study endpoints over time. We considered a broad range of potential 
confounders of these relations, including age, smoking, family history of CAD, hypertension, 
diabetes, hyperlipidemia, established CAD, resting heart rate, type of stressor (pharmacological 
or exercise), level of exercise, presenting symptom (angina pectoris), presence of ischemia on 
the exercise ECG. Cox models aiming at prediction should be used with a minimum of 10 
events per predictor variable (EPV). Simulation studies showed increasing bias and variability, 
unreliable confidence interval coverage, and problems with model convergence as EPV 
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rule of thumb is too conservative in analyses of causal influences based on observational 
data, and control of confounding may require adjustment for more covariates than the rule 
of 10 EPV allows [21]. Discounting of statistically significant associations from models that are 
based on 5-9 EPV and that aim to adjust for confounding is not justified. Hence, multivariable 
models that are based on our dataset (with 27 events) could safely contain 3 to 5 variables. 
We performed stepwise regression according to the backward deletion approach, applying 
a p-value of 0.15 as threshold for variable removal, to adjust for as many covariables as is 
resonably allowed by the (limited) number of events. We report crude and adjusted hazard 
ratios (HR) and corresponding 95% confidence intervals (CI).
It was not our intention to formally build an outcome prediction model. Still, all the continuous 
variables were assessed for linearity by entering a transformed variable in addition to the 
variable of interest. The natural logarithm and square transformations were used. A significant 
change in the -2 log-likelihood was considered as a sign of non-linearity, otherwise the linearity 
assumption was accepted. All variables met the linearity assumption. To check the proportional 
hazard assumption, i.e. that the hazard ratio for two subjects with fixed predictors is constant 
over time, log(-log[survival probability]) for different categories was plotted against time to 
ensure that the curves were reasonably parallel. In general, all proportionality assumptions 
were appropriate.
It appears that SSS and LVEF were associated with the incidence of study endpoints over time. 
We applied receiver operator characteristic (ROC) curve analyses to determine the optimal 
cut-off values for these variables that can be used for event prediction in clinical practice. 
Optimal cut-off values were defined as values resulting in the maximal sum of sensitivity and 
specificity. Subsequently, event-free survival curves were obtained according to the method of 
Kaplan and Meier, separating patients with a value below or above the threshold. Differences 
in event-free survival between patients were evaluated by log-rank tests.
For all analyses, a p value <0.05 was considered statistically significant. No correction was 
made to adjust for multiple comparisons.
RESULTS
Patient Characteristics
Four-hundred and fifty-three patients were followed. The patient baseline characteristics are 
shown in Table 1. Median age was 62 (53-70 years [25th-75th percentiles]). One-hundred and 
fourteen (26%) patients had known CAD. Of those patients 67 (15%) patients had sustained 
a MI, 67 (15%) patients experienced one or more revascularization procedures, and no patient 
had a history of cardiac arrest.
Perfusion and Function
Perfusion and function data is shown in table 2. Two-hundred and thirty-five patients (48%) 
had an abnormal perfusion study. Of those, 105 patients (45 %) showed an ischemic perfusion 
study. The median SSS was 5 (25th-75th percentiles: 0-22), the median SRS was 3 (25th-75th 
percentiles: 0-17), and the median SDS 2 (25th-75th percentiles: 0-3), median EDV was 70 ml 
(25th-75th percentiles: 56-89.5 ml), median ESV 24 ml (25th-75th percentiles: 16-39.5 ml), and 
74
LVEF 65.5 % (25th-75th percentiles: 54-73%), The median EDVi was 38 (25th-75th percentiles: 
32-49), and the median ESVi 13 (25th-75th percentiles: 9-22).
Outcome 
In 422 patients (93.2%) follow-up was complete until census or death. The average follow-up 
was 1.33 years (maximum 2.55 years). Twenty-seven patients suffered a hard event during 
follow-up, on average after 1.06 years (range 1 day - 2.50 years). Sixteen patients died of 
cardiac cause during follow-up, with a mean follow-up of 0.72 years (range 1 day - 2.22 years). 
Table 1.  Patient characteristics
Total number of patients 453
Age (yrs)* 62 (53-70) 
Risk factors for CAD





Body Mass Index * 26.9 (26.1-28.8)
Body Mass Area (m2)* 1.8 (1.7-2.5)
History CAD 114 (26%)
Myocardial infarction 67 (15%)
Revascularization 67 (15%)
* median (25th-75th percentiles), CABG: coronary artery bypass graft surgery; CAD: coronary artery 
disease; Body Mass Index according to the Mosteller Formula.
Table 2. Findings at gated SPECT imaging
Median 25th – 75th percentile range
A. Myocardial Perfusion
Total patient group (n=453):
SSS 5 0 - 22 0 - 67
SRS 3 0 - 17 0 - 65
SDS 2 0 - 3 0 – 34
B. Left Ventricular Function
Total patient group (n=453)
EDV (ml) 70 56 - 89.5 32 - 343
ESV (ml) 24 16 - 39.5 4 - 298
LVEF (%) 65.5 54 - 73 13 - 91
ESVi 13  9 - 22 2.0 - 156
EDVi 38 32 - 49 18 - 180
SSS = summed stress score, SRS = summed rest score, SDS = summed difference score, EDV = end-
diastolic volume, ESV = end-systolic volume, LVEF = left ventricular ejection fraction, ESVi: end-systolic 
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No hard events occurred during surgery or coronary intervention. Forty-seven soft events were 
recorded (mean follow-up 1.43 years; range 93 days – 2.52 years): 15 patients underwent 
coronary bypass surgery, and in 32 patients PTCA was performed. 
Patients with hard events during follow up had significant larger LV volumes, larger perfusion 
defects and lower LVEF than those without hard events. Patients with any cardiac event during 
follow up had significant larger LV volumes, more extensive perfusion defects, lower LVEF’s 
and larger reversible defects than those without [table 3].
Results based on univariate analysis are listed in Table 4. Summed stress score, SRS, all the 
function variables (EDV, ESV, EDVi, ESVi and LVEF) were predictive for CD and hard events. For 
hard events diabetes, smoking, presenting symptom (angina pectoris) and pharmacological 
stress test were also predictive. Age, diabetes, hyperlipedemia, smoking, history of MI, 
presenting symptom, pharmacological stress test, level of exercise and resting heart rate were 
predictive for any cardiac event. Also larger LV volumes (EDV and ESV), decreased LVEF, larger 
perfusion defects and ischemia were predictive for any cardiac event. 
The variables entered in the initial multivariable model for hard events included age, diabetes, 
hypertension, family history, hyperlipedemia, smoking, presenting symptom, history of CAD, 
history of MI, history of revascularization, pharmacological stress test, level of exercise, SSS, 
Table 3. Outcome: Perfusion and functional data.
A Hard events* No hard event* p-value
Myocardial perfusion:
SSS   25 (0 - 46) 4   (0 – 21) <0.01
SRS   18 (2 – 30) 2   (0 – 15) <0.01
Myocardial function:
EDV   85 (70 – 164) 69 (56 – 87) <0.01
ESV   45 (23 – 91) 23 (16 – 37) <0.01
LVEF   50 (31 – 64) 66 (55 – 73) <0.01
ESVi   24 (12 – 49) 12 (8 – 21) <0.01
EDVi   50 (37 – 84) 38 (32 – 47) <0.01
B Any Cardiac events* No cardiac event* p-value
Myocardial perfusion:
SSS   23 (4 – 35) 3 (0 – 19) <0.01
SRS   12 (2 – 24) 1 (0 – 14) <0.01
SDS     3 (0 – 13) 0 (0 – 1) <0.01
Myocardial function:
EDV   77 (66 – 103) 68 (56 – 86)   0.01 
ESV   34 (21 – 58) 22 (15 – 37) <0.01
ESVi   17 (10 – 33) 12 (8 – 21) <0.01
EDVi   42 (34 – 59) 38 (32 – 47)   0.01
LVEF   56 (44 – 68) 66 (56 – 73) <0.01
* values of the median (25th – 75th percentile). Only parameters that showed significantly differences 
between the patient groups are mentioned. SSS = summed stress score, SRS = summed rest score, SDS = 
summed difference score, EDV = end-diastolic volume, ESV = end-systolic volume, LVEF = left ventricular 
ejection fraction. ESVi: end-systolic volume index. EDVi = end-diastolic volume index.
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Table 4. Univariate and multivariate analysis of clinical data, perfusion and functional data assessed by 
gated SPECT.
Univariate analysis: hazard ratio 95% CI p-value
total mortality:
Age 1.02 0.97-1.06 NS
Diabetes 2.58 0.75-8.80 NS
Hypertension 2.08 0.56-7.69 NS
Family history 0.79 0.22-2.79 NS
Lipid 0.39 0.12-1.22 NS
Smoke 1.23 0.55-2.75 NS
CAD 0.95 0.31-2.93 NS
Symptom (AP) 0.99 0.79-1.24 NS
History MI 1.93 0.62-6.00 NS
History revasc 0.00 0.00-0.00 NS
Pharmacological 1.37 0.97-1.93 NS
Resting HR 1.03 0.92-1.42 NS
level of exercise 0.90 0.85-1.00 NS
ECG ischemia 0.72 0.04-1.89 NS
SSS 1.04 1.01-1.07 0.01
SRS 1.04 1.01-1.07 0.01
SDS 1.05 0.98-1.13 NS
EDV (ml) 1.01 1.00-1.07 <0.001
ESV (ml) 1.01 1.01-1.02 <0.001
LVEF (%) 0.95 0.92-0.97 <0.001
EDVi 1.03 1.01-1.04 <0.001
ESVi 1.03 1.02-1.04 <0.001
hard events:
Age 1.03 0.98-1.05 NS
Diabetes 1.03 1.24-7.44 0.02
Hypertension 0.91 0.40-2.11 NS
Family history 0.70 0.28-1.72 NS
Lipid 0.76 0.32-1.80 NS
Smoke 1.80 1.02-3.15 0.04
CAD 1.51 0.67-3.40 NS
Symptom (AP) 1.14 1.02-1.27 0.02
History MI 2.14 0.90-5.08 NS
History revasc 0.94 0.51-1.73 NS
Pharmacological 2.53 1.10-5.80 0.03
level of exercise 0.96 0.91-1.00 NS
Resting HR 0.99 0.96-1.02 NS
ECG ischemia 1.32 0.54-3.24 NS
SSS 1.05 1.03-1.07 <0.001
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Univariate analysis: hazard ratio 95% CI p-value
SDS 1.05 0.99-1.11 NS
EDV (ml) 1.01 1.01-1.02 <0.001
ESV (ml) 1.01 1.01-1.02 <0.001
LVEF (%) 0.95 0.93-0.97 <0.001
EDVi 1.02 1.01-1.03 <0.001
ESVi 1.02 1.01-1.03 <0.001
Any cardiac events:
Age 1.03 1.01-1.05 0.01
Diabetes 1.88 1.07-3.30 0.03
Hypertension 1.00 0.59-1.67 NS
Family history 1.21 0.69-2.11 NS
Lipid 2.03 1.13-3.64 0.02
Smoke 1.76 1.27-2.45 0.001
CAD 2.27 1.37-3.75 0.001
Symptom (AP) 1.11 1.04-1.20 0.004
History MI 2.36 1.35-4.12 0.003
History revasc 1.09 0.80-1.50 NS
Pharmacological 1.82 1.10-3.00 0.02
Resting HR 0.98 0.96-1.00 0.03
level of exercise 0.97 0.94-0.99 0.01
ECG ischemia 1.42 0.81-2.48 NS
SSS 1.05 1.03-1.06 <0.001
SRS 1.03 1.02-1.05 <0.001
SDS 1.11 1.08-1.14 <0.001
EDV (ml) 1.01 1.00-1.01 0.01
ESV (ml) 1.01 1.00-1.01 0.01
LVEF (%) 0.98 0.96-0.99 <0.001
EDVi 1.01 1.00-1.02 0.02
ESVi 1.01 1.00-1.02 0.01
Multivariate analysis
hard events:
LVEF (%) 0.97 0.94-1.00 0.03
SSS 1.03 1.01-1.06 0.02
Any cardiac events:
SSS 1.06 1.03-1.08 <0.001
Hard events = myocardial infarction, cardiac arrest, ventricular fibrillation and total mortality. Any cardiac 
event= myocardial infarction, cardiac arrest, ventricular fibrillation and total mortality, revascularization 
procedure. Symptom (AP) = angina pectoris as presenting symptom.  Pharmacological = pharmacological 
stress test. Resting HR= resting heart rate. Level of exercise = % of the target level of exercise adjusted 
for gender, age, length and weight. ECG ischemia = ischemia on stress ECG. EDV = end-diastolic volume.
ESV = end-systolic volume. ESVi= end-systolic volume index. EDVi= end-diastolic volume index. LVEF = 
left ventricular ejection fraction. SSS = summed stress score. SRS = summed rest score. SDS = summed 
difference score. CAD = coronary artery disease. CI = confidence interval. MI= myocardial infarction
Table 4: (Continued)
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SRS and all the function variables (EDV, ESV, EDVi, ESVi and LVEF). For any cardiac events age, 
diabetes, hypertension, family history, hyperlipedemia, smoking, presenting symptom, known 
CAD, history of MI, history of revascularization, pharmacological stress test, resting heart rate, 
level of exercise, ischemia on stress ECG, SSS, SRS and all the function variables (EDV, ESV, 
EDVi, ESVi and LVEF) were entered in the model.
Multivariate analysis showed that summed stress score and LVEF provided independent and 
incremental prognostic value for hard events (beyond clinical data and/or perfusion variables 
respectively). Summed stress score provided independent and incremental prognostic value 
for any cardiac event (table 4).
Survival
The annual CD rate as function of percent stress defect for <5%, 10-20% and >20% hypoperfused 
myocardium was <0.7%/year, 1.6%/year and 4.6 %/years respectively. The annual hard event 
rate for these subgroups are 1.0%/year, 3.1%/year and 8.3%/year respectively. ROC curve 
analysis was used to determine the optimal cut-off values for LVEF and SSS to predict outcome. 
For hard events optimal cut-off values for these different parameters could be determined. 
According to these cut-off values, patients could be divided into 2 groups (Figure 1 and 2). An 
LVEF < 52% (area under the curve [AUC] 0.75) was associated with a significantly higher risk of 
hard events (p< 0.0001). Patients with a LVEF < 52% had an annual event rate of 11.6% with 
an annual CD rate of 6.6%, whereas those with an LVEF # 52% had an annual hard event rate 
of 1.7%, and an annual CD rate of 0.6%. For SSS, maximal separation could be found using a 
cut-off score of 22 (AUC 0.84; p=0.0001). The annual hard event rate for patients with an SSS 
# 22 was 10.5%, whereas those with an SSS <22 had an annual hard event rate of 2.5%. 
For any cardiac event optimal cut-off value for SSS could be determined (figure 3). Maximal 
separation could be found using a cut-off score of 14 (AUC 0.81). The annual any cardiac event 
rate for patients with an SSS # 14 was 20.8%, whereas those with an SSS <14 had an annual 
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DISCUSSION
Our results show that relatively young female patients with hard events had significant larger 
LV volumes, increased defect sizes and lower LVEF’s than those without hard events. Also, 
patients with any cardiac event during follow up had significant larger LV volumes, increased 
defect sizes and lower LVEF’s than those without any cardiac events. Moreover, patients with 
any cardiac event had significant larger ischemic defects. For hard events and cardiac death 






0 180 360 540 720
Follow -up (days)
Patients at risk 
Cumulative percentage of patients with hard cardiac events  
LVEF %52
LVEF >52
453 396 306 196 80










453 396 306 196 80
Cumulative percentage of patients with any cardiac event 
Figure 3. Any cardiac endpoint according to the the cut-off values for SSS.
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hard events diabetes, smoking, presenting symptom and pharmacological stress test were also 
predictive. Age, diabetes, hyperlipedemia, smoking, history of MI, presenting symptom, resting 
heart rate and pharmacological stress test were predictive for any cardiac event. Also larger LV 
volumes (EDV and ESV), decreased LVEF, larger perfusion defects and ischemia were predictive 
for any cardiac event. Summed stress score obtained by quantitative gated SPECT imaging 
had independent and incremental prognostic value for both hard events and any cardiac 
event in female patients beyond clinical data. For hard events also LVEF had independent 
and incremental prognostic value beyond clinical and perfusion data. Using these perfusion 
and functional data, female patients with increased risk of having subsequent serious cardiac 
events could be identified. Using ROC curve analysis, cut-off values for LVEF of 52% and SSS 
22 for hard events and SSS of 14 for any cardiac event yielded the highest sensitivity/specificity 
(discriminative power) to predict increased cardiac risk. An SSS > 22 and a LVEF of <52% were 
predictive for subsequent hard events. An SSS> 14 was predictive for any cardiac event.
To our knowledge, this is the first study to show that large ischemic and mixed defects are not 
all at high risk of events. Only a combination of perfusion and function allows to effectively 
risk stratify this population and give an individualized risk estimates for this heterogeneous 
population. Therefore, perfusion data per se are definitely not enough to make individualized 
prognostic statements.
Prognostic Value of Perfusion Data
Our perfusion data extend previous findings that average defect size was largest in those 
patients who suffered a hard event. In particular the SSS has been shown to be a powerful 
independent predictor of cardiac events [10, 22-24]. 
However, most of the observations have been made in a mixed gender population [10, 22-24]. 
Sharir et al [11] showed that for CD and MI, perfusion data provided a larger proportion of the 
prognostic information for women than they did for men. We demonstrated that perfusion 
data has incremental value over clinical data, both for hard events and any cardiac event. In 
particular women with moderate to severe perfusion defects had a high annual hard event 
rate. Those with a normal perfusion image have very low annual event rate. Stress-induced 
ischemia was predictive in women who suffered any cardiac event but had no incremental 
prognostic value for predicting hard events. This is in line with previous findings that suggest 
that the extent of defect size and functional abnormalities are more predictive for hard events 
(CD and MI), whereas the extent of ischemia is more predictive for soft events and/or MI 
[10,25-27]. By using gated SPECT perfusion imaging, women at increased risk of having a 
cardiac event could be identified. 
Most of the published data used a 20-segment approach. Berman et al [14] showed that in a 
17-segment approach the apex and adjacent short-axis slice of the LV is less overweighed. There 
was a trend toward less frequent borderline scans with more normal and severely abnormal 
scans in the overall population. They found in the patients who shifted from abnormal scan by 
20-segment model to normal scan in the 17-segment approach an equal cardiac death rate to 
other normal patients.
Berman et al [14] found a significantly higher annual CD rate for women compared to man 
in group of patients with moderately to severe perfusion defects. We found the same annual 
CD rates for the patients with normal images (stress defect <5% of the myocardium, 0.5% 
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defects (4.6% versus 6.4%) was found. This may be explained by the fact that our population 
was 10 years younger. In a matched aged group, Groutars et al [24] found similar events 
rates compared to our study (0.4% vs 0.7% annual CD rate for normal perfusion, 2.1% vs 
2.4% annual CD for moderately-severely abnormal images). Similar results were found for 
hard cardiac events. Our optimal cut-off value to identify patients at high risk for hard events 
was 22 (32% of the left ventricle). Patients with a SSS < 22 had the same annual hard event 
rate demonstrated by Zellweger et al [28] for mildly abnormal scans (2.5% vs 2.4%). Travin 
et al [10] reported similar annual hard event rates for patients with mildly abnormal perfusion 
images compared to patients with a SSS < 22 in our study (2.5% vs 3.0%). The cut-off value 
of SSS>22 suggests that the major part of the hard events occurs in patients with very large 
perfusion defects. Therefore, the group of female patients with severe perfusion defects is 
diverse with different outcome. In our group, using our cut-off values, it is possible to identify 
females at increased risk. 
A few data is reported on any cardiac events. Groutars et al [29] reported good outcome 
in patients with normal perfusion studies. The annual event rate was 0.8% for any cardiac 
events. Schinkel et al [30] found that for all cardiac events an abnormal scan and SSS had 
independent prognostic value, which is in line with our results. 
Prognostic Value of Functional Data
Our data showed that functional data obtained from technetium-99m tetrofosmin gated 
SPECT were predictive for cardiac events. 
We found that patients who suffered a cardiac event (for subgroups: cardiac death, hard 
events and any cardiac event) during follow-up had significantly increased LV volumes and 
a significantly lower LVEF. Only for hard events functional data (LVEF) had independent 
incremental prognostic value. Our results underscore previously published data on the 
prognostic value of gated SPECT imaging [26-34]. 
Sharir et al. [9] showed that perfusion variables and ESV were powerful markers in the 
prediction of total coronary events, whereas in the prediction of CD, post-stress LVEF and 
ESV were independent predictors and had incremental value over perfusion data. According 
to their criteria, patients were at increased cardiac risk when they had a LVEF < 45% and an 
ESV >70 ml. The study by Sharir et al [9] was performed in a very large cohort of more than 
1600 patients, representing a heterogeneous population of patients with CAD in terms of LV 
function abnormalities. 
Recently, Sharir et al [11] showed lower limits of LVEF in women and men with a low likelihood 
of CAD. Fifty-one percent (mean-2 SDs) and 43% respectively. They also report upper limits 
for ESVi and EDVi for both genders (27 ml/m2 and 60 ml/m2 for women and 39 ml/m2 and 75 
ml/m2 in men resp.). 
Compared to the data reported by Sharir et al. [9], the annual event rate in our group of 
women with an LVEF #52% was similar to the annual event rate of a mixed population of 
patients with an LVEF#45% (regardless of the degree of perfusion abnormality). 
To summarize, functional data obtained from technetium-99m tetrofosmin gated SPECT can 
be used to identify women at increased cardiac risk. The cut-off value for LVEF used in a mixed 
gender population is not applicable to studies in women. Women at increased risk of major 
adverse cardiac events, those with an LVEF <52% and/or a SSS of > 22, may benefit from more 
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aggressive invasive therapy. However, further randomized prospective studies are needed to 
show better clinical outcome of aggressive therapy in these patients.
Study Limitations
It is known that in patients with small hearts LV volumes, especially ESV, measured by the 
QGS technique are often underestimated and LVEF is often overestimated. In general, this 
phenomenon occurs more in women than in men because women tends to have smaller LV’s. 
However, previous studies [11] showed a significant correlation between ESV and EDV versus 
BSA. Another study [13] showed a systematically underestimation of volumes, more so for 
small volumes. As long as the QGS technique has a high reproducibility (for each individual 
center) [7,8, 35] the data on LV function can be used for risk stratification. 
It would have been interesting to demonstrate whether LV volumes add prognostic information 
over LVEF. However, both variables are strongly interrelated, implying that LV volumes and 
LVEF cannot simultaneously be incorporated in a statistical model. Consequently, based on our 
data it is virtually impossible to decide whether LV volumes add incremental value to LVEF. 
In the present study we included all female patients who underwent a myocardial perfusion 
study, without screening patients for pre-test likelihood of CAD. However, according to the 
used ESC guidelines, most patients have an intermediate likelihood of CAD. In the present 
study, ischemia did not show independent incremental prognostic value for predicting any 
cardiac events, but the study population was relatively small, the follow-up period was rather 
short and not for 100% complete (a total of < 5% lost to follow up), and the number of 
events was low. Future studies will be needed to further separate the group of patients with 
combined perfusion and functional high risk features.
CONCLUSION
In women, perfusion and functional parameters derived from quantitative gated technetium-
99m tetrofosmin SPECT imaging can adequately be used for cardiac risk assessment. Using 
quantitative gated SPECT, female patients with an LVEF < 52% or an SSS #22 are at increased 
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Gated SPECT myocardial 
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and prognostic tool in clinical 
cardiology
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Coronary artery disease (CAD) is the major cause of morbidity and mortality in industrialized 
western countries. Early detection of CAD may decrease morbidity and mortality. Myocardial 
perfusion scintigraphy (MPI) is an important diagnostic tool both in patients with known and 
suspected coronary artery disease (figure 1). Moreover, MPI provides prognostic information 
and can therefore be used for optimal risk stratification. The improvement in survival after acute 
myocardial infarction has resulted in a markedly increased population of elderly patients with 
extensive cardiac disease, often associated with a diminished cardiac function. In this setting it 
becomes more important to go from a diagnosis of coronary artery disease towards the level 
of risk stratification. This need for risk stratification applies to patients with both acute and 
chronic CAD. Gated single photon emission computed tomography (SPECT) imaging provides 
beside regional perfusion data additional information on left ventricular (LV) wall motion, 
wall thickening, LV cavity volumes, and LV ejection fraction (LVEF). With the introduction of 
automated quantitative software programs in MPI, objectively defined abnormality thresholds 
can be set. This increases the diagnostic accuracy.
Left: normal perfusion study. Right: an anterior and lateral reversible and inferior fixed perfusion defect. 
SA= short axis, VLA= vertical long axis, HLA= horizontal long axis.


























































   6
Figure 2. Left: Screen display with short and long axis images with overlaid endocardial and epicardial 
contours. Short axis images are used as input. Right: Four dimensional (three dimensional plus time) 
display screen utilized for the assessment of global and regional myocardial function. Gated short axis 
images are used as input.
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The purpose of this educational paper is to give an outline of the additional value of automated 
gated SPECT in diagnosis and risk assessment of CAD. 
GATED SPECT
Gated SPECT takes full advantage of the properties of 99m-technetium (99mTc) perfusion 
agents, namely high count rates and stable myocardial distribution over time. Because 
the tracer distribution in the myocardium is stable, spatial and temporal changes in the 
myocardial tracer activity during the cardiac cycle reflect regional myocardial wall motion and 
wall thickening. The advantage of this technique is the assessment of both perfusion and 
function (LV wall motion and thickening, LV cavity volumes, LV cavity volumes, LVEF) during 
one single acquisition. Complete automatic quantitative algorithms have been developed [1]. 
Measurements of LV function from gated SPECT are implemented by fully exploiting the three-
dimensional nature of the tomographic datasets (figure 2). Functional parameters assessed 
by gated SPECT have shown to have good to excellent concordance with well-known other 
imaging modalities [1]. 
DIAGNOSTIC VALUE OF GATED SPECT MYOCARDIAL PERFUSION 
IMAGING
The sensitivity of exercise perfusion imaging for detecting angiographicaly significant CAD 
ranges from 85-91% and the specificity ranges from 70-94% [2]. The addition of SPECT 
to exercise testing increases the diagnostic accuracy to detect CAD, with no significant 
differences between different tracers or between men and women [2]. Several factors can 
effect the diagnostic performance of MPI: referral bias -this means that of the patients with 
5-point scoring system: 
0=normal,  Summed stress score (SSS).
1= equivocal,  Summed rest score (SRS).
2=moderate,  Summed difference score (SDS): SRS - SSS
3= severe reduction of radioisotope uptake,  
4= absence of detectable radiotracer in a segment.
percentage abnormal perfusion of total myocardium: (score/68) x 100%



























































   6
normal studies only those with a high suspicion of CAD are referred for coronary angiography-, 
reduced stress tolerance, anti-anginal medication and technical imaging problems such as 
tracer activity below diaphragm, photon attenuation and scatter, patient motion, low count 
statistics, reconstruction artifacts [2].
The addition of LV functional parameters assessed by gated SPECT has considerably improved 
the diagnostic value [1,2]. An attenuation artifact will usually show a fixed perfusion defect 
with concomitant preserved wall thickening and/or motion, whereas a region with a fixed 
perfusion defect due to myocardial infarction will show absence of wall thickening and or 
motion. Gated SPECT may show absence of wall thickening potentially indicating necrosis or 
stunning, and conversely, gated SPECT may show concomitant preserved wall thickening in 
the infarct region suggesting preserved viability. 
Potential limitation of perfusion imaging is the measurement of relative myocardial blood flow 
rather than absolute blood flow. In patients with multivessel CAD, the degree of ischemia 
may be underestimated because of globally reduced perfusion of the LV. Overall sensitivity for 
identifying any SPECT abnormality of the combined perfusion/ function assessment in three-
vessel disease is 80-95%, and for two or single vessel disease 92% and 86%, respectively, with 
an overall specificity of 72% [3]. 
Transient ischemic LV dilatation on myocardial perfusion scintigraphy indicates significant 
enlargement in LV size on the stress images compared with the rest images. Abnormal transient 
ischemic LV dilatation is related to a greater amount of ischemic burden as well as multivessel-
type or LAD territory perfusion abnormality [4].
PROGNOSTIC VALUE OF (GATED) SPECT MYOCARDIAL PERFUSION 
SCINTIGRAPHY 
The underlying risk in the population varies with a patient’s pretest risk. A patient’s pretest risk 
may be estimated as low, intermediate or high according to risk score models (eg, Framingham 
risk score). Selection of candidates for myocardial perfusion imaging is based on Bayesian 
theory. Post-test likelihood becomes a function of a patient’s pretest risk. Intermediate-risk 
patients may shift posttest to low or high risk. Optimal candidates for imaging include patients 
at intermediate-risk for cardiac death or nonfatal myocardial infarction [2]. Intermediate-risk 
patients are those with an annualized event rate ranges from 1 to 3% per year. Numerous 
studies have shown the incremental prognostic value of myocardial perfusion imaging also 
after clinical assessment, exercise electrocardiography and coronary angiography. Important 
variables for risk stratifications are type of stress-test [2], extent and severity of inducible 
ischemia [5] and/or perfusion defect [6], increased lung uptake of thallium-201 (indicating 
elevated pulmonary capillary pressure) [7], transient ischemic LV dilatation [4] and LVEF [8, 
9]. Calculation of the number of segments involved on a multislice tomographic evaluation of 
the SPECT study can be used to calculate both the extent and severity of the hypoperfused 
myocardium. Using sequential short axis slices, a polar map can be evaluated either visually or 
quantitatively to assess the total ischemic burden. The ischemic/hypo-perfused burden can be 
calculated by summed difference score (SDS) or summed stress score (SSS) (figure 3). These 
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indices can be converted to a percentage of the total myocardium involved with ischemic or 
fixed defects.
The normal perfusion scintigraphic study
A normal study is characterized by a SSS < 4 (in 17 segment model) or < 5% hypoperfused left 
ventricular myocardium. Patients with normal perfusion images have excellent survival rates 
with low annual event rates i.e. an annual cardiac death or myocardial infarction of 0.7%/ 
year, similar to that of asymptomatic population even in the group of patients with known 
or suspected CAD [2]. However, a number of variables, including pharmacologic stress test, 
diabetes mellitus, advanced age are identified as markers of increased risk in which the annual 
event rate may exceed 1%/year. Overall, patients with a normal perfusion study are at low 
risk. Scintigraphic data provide incremental prognostic value compared to clinical and exercise 
data alone. No significant differences were seen for use of 201-thallium, 99m-Tc sestamibi or 
99m-Tc tetrofosmin [2]. 
The abnormal perfusion image
Berman et al [10] reported a cut-off value of 5 % hypoperfused myocardium at stress as 
an optimal criterion for distinguishing images associated with a low (<1/y) risk on coronary 
death from those associated with a higher risk of cardiac death. The risk on major adverse 
cardiac events (MACE) increases logarithmically over patients with low-risk findings in the 
setting of moderately-severely abnormal studies [11]. High risk patients (annualized event 
rates 3% or higher [11]) are those with moderately to severely abnormal scans, multivessel 
perfusion abnormalities or a hypoperfused myocardium of > 10%. Patients with abnormal 
images have on average an annual event rate of 6.7% (cardiac death or myocardial infarction) 
[2]. Different studies have shown an annual cardiac death rate of 1.0-2.7% for mildly (5-10% of 
the myocardium), 2.1-4.0 moderately severe (10-15%) and > 4.2 % for severely (> 15%) post-
stress perfusion abnormalities. For myocardial infarction, annual event rates of 0.8-2.5% for 
mildly abnormal, 2.3-4.0% for moderately and >2.9% severely perfusion abnormalities were 
reported [10,12,13] with higher rates of MACE for patients undergoing pharmacological stress 
versus exercise stress [12]. The extent of fixed defects provides a better estimation of cardiac 
death, whereas reversible defects often predict acute ischemic events [2].
It has been shown that resting or exercise LVEF determined by radionuclide angiography is 
a major determinant of long-term survival in patients with CAD. In patients with normal LV 
function, nonfatal infarction accounted for at least 50% of initial events, whereas in patients 
with severe LV dysfunction death was the predominant event [9]. 
With gated SPECT additional information on regional left ventricular function can be assessed. 
Sharir et al. [14] found that patients with severe perfusion abnormalities but an end-systolic 
volume <70 ml had very low cardiac death rates (0.4%/year), whereas patients with only mild/
moderate perfusion defects but an endsystolic volume >70 ml had high cardiac death rates 
(8.2%/year). Even patients with preserved global LV function (LVEF>45%) but an end-systolic 
volume >70 ml had a relatively high death rate (2.6% versus 0.5%; P=0.02). Patients with 
an LVEF<45% and mild/moderate or severe perfusion abnormalities had high mortality rates 
(9.2% and 5.7% respectively), whereas patients with an LVEF >45% had a cardiac death rate 
<1%/year, regardless the degree of the perfusion abnormality (figure 4 and 5). Post-stress 
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Figure 4. Cardiac death rate as a function of perfusion abnormality 
and LVEF and ESV (adapted from reference 14).
Figure 5. Cardiac Death rate as function of LVEF and ESV (adapted 
from reference 14).
Figure 6. Annual cardiac death rate of men vs women as a function 
of percent stress defect (Adapted from reference 10).
- Stress percent Myocardium abnormal. 
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prognostic information over perfusion data alone [14]. The same authors studied the value of 
gated SPECT in the assessment of outcome-specific (nonfatal myocardial infarction vs cardiac 
death) independent predictors [8]. Post-stress LVEF is a good predictor for cardiac death, 
whereas the amount of ischemia is a very good predictor of nonfatal myocardial infarction. 
Integration of LVEF and SDS yielded effective stratification of patients into low- (<1%/year), 
intermediate- (2%-3%/year), and high-risk subgroups (>4%/year) of cardiac death. Patients 
with LVEF >50% and a large amount of ischemia were at intermediate risk whereas those with 
mild or moderate ischemia were at low risk. Patients with LVEF between 30% and 50% were 
at intermediate risk even in the presence of only mild or moderate ischemia. LVEF <30% was 
predictive of high risk, irrespective the amount of ischemia. Transient ischemic LV dilatation 
can be assessed by gated SPECT. Even in patients with normal myocardial perfusion study, 
transient ischemic LV dilatation has independent and incremental prognostic value [4]. High risk 
has been defined by a transient ischemic LV dilatation > 1.21, regardless the type of stress.
Risk assessment in women.
After myocardial infarction increased mortality and reinfarction have been observed in women 
after myocardial infarction compared to men. The large proportion of atypical symptoms, 
higher incidence of associated disease (e.g. hypertension, diabetes mellitus) and the higher 
age at presentation account for the worse outcome. Beside this, Exercise ECG has a lower 
diagnostic and prognostic accuracy in women. It is influenced by multiple factors, i.e. exercise 
capacity and hormonal status. The increased age at presentation is often associated with 
lower exercise capacity and an inability to attain maximal stress [15]. However, exercise stress 
SPECT yields independent and incremental prognostic information for both genders [10]. In 
fact, women with severe abnormalities may have a worse outcome than men with severe 
abnormalities (figure 6)[10,15]. Post-stress LVEF and ESV index (ESV/ body surface area = ml/
m2) by gated SPECT provide incremental prognostic information over perfusion in women and 
men [16]. In women perfusion variables add more prognostic information than function data 
whereas in men function variables are more powerful. Women and men with a low likelihood 
of CAD have different upper limits for ESV index (women: 27 ml/m2 vs men: 39 ml/m2) and 
EDV index (women: 60 ml/m2 vs men: 75 ml/m2), and different lower limits for LVEF (women: 
51% vs men: 43%). Combination of severe ischemia and abnormal LVEF or ESV index identifies 
women at very high risk of MACE [16]. LVEF and SSS assessed by gated SPECT scintigraphy have 
incremental prognostic value, with a cut-off value for LVEF < 52% or an SSS #22 for women 
at increased risk for subsequent hard events (SSS#14 are at increased risk for any cardiac 
events). Previous studies have shown that the annual event rate in women with an LVEF #52% 
was similar to the annual event rate of a mixed population of patients with an LVEF#45% 
regardless of the degree of perfusion abnormality [14, 17]. Women with large ischemic and/
or mixed defects are not all at high risk of cardiac events. Only a combination of perfusion 
and function allows to effectively risk stratify this population and give an individualized risk 
estimates for this heterogeneous population [17].
Risk assessment before non-cardiac surgery.
Inducible ischemia on myocardial perfusion scintigraphy for perioperative death or infarction 
has an excellent negative predictive value (98.6%) [2]. The extent of reversible defects 
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Figure 7. Risk stratification by Myocardial Perfusion Scintigraphy for patients with suspected or known 
coronary artery disease based on stress percent abnormal myocardial perfusion or percent ischemia 
and post-stress left ventricular ejection fraction (based on references 2, 8,14 and 15).
- LVEF= left ventricular ejection fraction.
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is a predictor of late cardiac events [18]. Addition of Gated SPECT functional variables allows 
further selection of low-risk patients [18]. Perioperative cardiac event rate increases with 
decreasing LVEF. The decision of nuclear testing should be made based upon urgency of the 
surgery and its cardiac risk, individual risk factor and exercise tolerance of the patient. Patients 
with intermediate risk or with low-risk and low exercise tolerance who have to undergo 
moderate-risk or high-risk surgery will need further investigation. Also patients at high clinical 
risk require further investigation even for low-risk surgery.
Risk assessment after acute myocardial infarction.
Recent studies in patients after acute myocardial infarction have shown that adenosine MPI 
is a reliable method for risk stratification and guidance for therapeutic decision early after 
hospital admission [19]. Total perfusion defect size has shown to be the most important 
independent risk predictor, followed by ischemic perfusion defect size and LVEF [19,20]. In this 
patient group a LVEF of < 40% is an independent predictor of cardiac death, acute myocardial 
infarction or hospitalization for unstable angina, congestive heart failure, or revascularization 
[20]. Low-risk patients (irrespective of age, gender, site of infarction, or clinical risk) have small 
perfusion defects, preserved LVEF and minimal residual ischemia. Such low-risk patients can be 
medically treated as alternative to an invasive evaluation, with a quite acceptable low overall 
event rate [19]. 
It is important to identify the myocardium at risk but with the potential to improve LV 
function after acute myocardial infarction. Therefore, accurate assessment of the extent of 
viable myocardium in the dyssynergic LV can play an important role in the early management 
of patients with acute myocardial infarction. Evaluation of contractile reserve by means of 
low-dose dobutamine (LDD) gated SPECT with Tl-201 has incremental value over perfusion 
assessment alone, in the prediction of function recovery in patients early after AMI (within 48 
hours) [21]. Mean Tl-201 uptake score or ischemic area is associated with the recovery of wall 
motion. The number of segments with preserved uptake at rest and the number of akinetic or 
dyskinetic segments with preserved uptake and wall thickening are independent predictors of 
events (cardiac death or nonfatal myocardial infarction) [22].
Prognostic value in diabetic patients.
Patients with diabetes mellitus are at increased risk for CAD. In these patients CAD can develop 
on earlier age and might be more advanced at diagnosis, and have increased mortality and 
morbidity after myocardial infarction [23]. Early testing for CAD can aid in risk stratification. 
Multivariate analysis has shown that myocardial perfusion imaging abnormalities, retinopathy 
and duration of diabetes are independent predictors of cardiac events [24]. The prognostic 
value of MPI is equivalent in diabetes and nondiabetics. The SSS provides incremental 
prognostic information [25]. Diabetic women with mildly perfusion abnormalities have twice 
the annual mortality rate (3.3%) of diabetic men with the same abnormalities (1.6%) [26]. 
Nondiabetic women with normal, moderately abnormal, and severely abnormal scans have an 
annual MACE rate of 0.8%, 2.8%, and 6.1% respectively; the cardiac event rates increase to 
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Patient selection for revascularization therapy.
MPI can be used to identify patients who benefit from revascularization as opposed to medical 
treatment [27]. Although LVEF predicts cardiac death, only inducible ischemia identifies who 
will have a short-term benefit from revascularization [28]. Patients with small ischemic defects 
(5-10%) benefit from medical therapy. Patients with >10% ischemic myocardium have an 
increased survival benefit from revascularization. In these patients revascularization nearly 
neutralizes the prognostic impact of ischemia [27].
Viability-guided revascularization may reduce perioperative morbidity and mortality [28]. 
Patients with viable myocardium show improvement in function after revascularization [29]. 
On the other hand, patients with viable tissue treated medically had increased event rates [30]. 
Several methods have been established to differentiate patients with myocardial viability from 
patients without viable myocardium: 1) 201Tl imaging to assess myocardial perfusion and cell 
membrane integrity, 2) dobutamine echocardiography to assess myocardial contractile reserve, 
3) F-18-fluorodeoxyglucose positron emission tomography (18FDG-PET) imaging to assess the 
myocardial metabolic state, and 4) the use of 511 keV collimators to detect viable myocardium 
with FDG-SPECT. FDG/Tl-201 SPECT can predict regional ventricular functional recovery 
after revascularization [31]. In patients with CAD and severe LV dysfunction, information of 
perfusion and wall motion assessed by gated SPECT significantly improved the sensitivity and 
overall accuracy for determination of viability in comparison with perfusion alone [32,33]. 
18FDG SPECT demonstrated more evidence of myocardial viability than either gated 99mTc-
sestamibi wall thickening or delayed 201Tl SPECT [34].
GENERAL CONCLUSIONS
Gated SPECT allows the analysis of LV perfusion and function during the same acquisition. 
Gating provides a valuable adjunct to 99mTc-sestamibi or tetrofosmin SPECT in characterizing 
perfusion abnormalities and potentially improving test specificity. Gated SPECT is a valuable 
tool in risk stratification (figure 7) because it provides information of LV end systolic volume 
and LVEF, which are both important prognostic parameters and have incremental value 
over perfusion alone. Gated SPECT imaging may be used for stratification of candidates for 
revascularization as it allows the analysis of residual wall thickening in a region with a fixed 
perfusion defect or depressed wall motion in a region with a moderate or mild perfusion 
defect indicating hibernation. Gated SPECT provides important additional information beyond 
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C h a p t e r   7
Summary, general discussion 
and future perspectives

SUMMARY, GENERAL DISCUSSION AND FUTURE PERSPECTIVES
Summary
In this PhD thesis we evaluated the added prognostic value of functional data assessed by 
quantitative gated single photon emission computed tomography (SPECT) in patients with 
(suspected) coronary artery disease. Substantial data has been reported on the prognostic 
value of myocardial perfusion imaging in mixed population. We evaluated the technique on 
subgroup level. Important perfusion or function predictors of worse outcome have been 
identified. Beyond this, multiple analysis have been done to maximally separate high risk 
patients from those without increased risk of major adverse cardiac events.
Techniques for automated quantitative approach of myocardial perfusion imaging have 
been developed to minimize inter- intra operator variability and increase reproducibility. 
With regard to the validation of the Cedars-Sinai’s Quantitative SPECT (QGS) software, in 
cross-validations with other techniques, results have been evaluated on population level. 
Any failure in specific subgroups will be diluted by the large amount of successful analysis 
over the investigated population. The software used in the QGS technique is complex and, 
under certain conditions, falls back on alternative algorithms. This complexity makes cross-
validations with other techniques difficult. In Chapter 2 we evaluated the reliability of the 
quantitative assessment of the left ventricular volumes (end-diastolic and end-systolic), left 
ventricular ejection fraction and regional segmental wall motion and wall thickening based on 
a system analyses. In this approach we tried to identify conditions under which the algorithm 
becomes operator-dependent. We especially reviewed the algorithm for interfering clinical 
conditions. The operator-dependent factors contain only the reorientation that the operator 
has to perform after raw data acquisition. The rest of the data processing can easily kept 
constant and is assumed to be stable. We selected series of prototypes. The prototypes 
consisted of a) normal perfusion, b) perfusion defects in all perfusion regions, c) perfusion 
studies of patients with angiographic confirmed normal coronary arteries, proximal (>70% 
luminal stenosis) single and multiple vessel disease, and d) spurious activity in close proximity. 
While defining and re-orienting the volume containing the left ventricle, the operator adjusted 
8 variables/ degrees of freedom. The results were expressed as a coefficient of variation. 
Separate coefficients of variation were calculated per distinct degrees of freedom. A segment 
was considered not robust when the coefficient of variation did exceed 20% in a single degree 
of freedom, 15% in at least 2 degrees of freedom, or 10% in at least 3 degrees of freedom. 
Our results showed excellent reproducibility for left ventricular ejection fraction and volumes. 
Normal perfusion and the vessel disease prototypes showed an excellent coefficient of variation 
(for all re-orientation steps [33/prototype]) mostly below 5% for left ventricular functional 
parameters. However, regional wall motion and thickening became less reliable in the presence 
of large perfusion defects or artifacts. Therefore, we concluded that quantitative estimates 
for regional left ventricular functional data show excellent reproducibility using automated 
gated SPECT. However, there may be substantial operator dependency in the presence of 
large defects or spurious activity in close proximity. Gated acquisition of the stress myocardial 
perfusion images 30 minutes post-stress reflect myocardial perfusion at maximal stress whereas 
left ventricular function, which is evaluated 30-45 minutes post-stress, represents the resting 
situation. Several studies have shown that patients with stress-induced ischemia may develop 
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until 60 minutes post-stress or even longer. Before starting the gated SPECT study it is not 
known which patients will show stress-induced ischemia. Therefore, it is impossible to stratify 
patients who should be gated during the rest study acquisition beforehand in order to avoid 
the possibility of stunning which leads to a lower left ventricular ejection fraction compared to 
the rest left ventricular ejection fraction. 
In Chapter 3 the left ventricular function post-stress in patients with a previously sustained 
myocardial infarction were compared to the basal left ventricular function at rest. In this 
patient group we studied the influence of different stress modalities (pharmacological stress 
and conventional exercise stress) on change in left ventricular ejection fraction post-stress. 
We investigated 58 patients with a previous myocardial infarction. In all patients myocardial 
perfusion and left ventricular ejection fraction was determined from both the rest and post-
stress acquisition. The reproducibility of the left ventricular ejection fraction was excellent 
within a margin of 2%. In 33 (57%) patients the left ventricular ejection fraction post-stress 
was # 2% lower compared to the rest left ventricular ejection fraction. In a matched control 
group of 23 patients with a low likelihood of coronary artery disease there was no significant 
change in left ventricular ejection fraction post-stress compared to rest (0.04%± 3.2%, p=ns). 
Conversely, the patient group with a previous myocardial infarction showed a significant lower 
left ventricular ejection fraction post-stress compared to rest (-1.9%± 4.2%, p=0.002). The 
presence of reversible ischemia, which occurred in 16 (28%) patients, did not interact with the 
change in left ventricular ejection fraction post-stress compared to rest (p=ns). This finding 
implies that the presence of reversible ischemia is not a prerequisite for the development 
of myocardial stunning in patients with a previous myocardial infarction. Furthermore, the 
used stress modality (exercise test or adenosine) did not influence the results. From this study 
we concluded that in patients with a previous myocardial infarction, left ventricular function 
post-stress may not represent true resting left ventricular function. Left bundle branch block 
pattern on the electrocardiogram severely reduces the diagnostic and prognostic accuracy 
of myocardial perfusion scintigraphy. The addition of regional left ventricular (LV) function 
parameters by gated SPECT improved the diagnostic accuracy. In Chapter 4, we studied 
the incremental prognostic value of quantitative technetium-99m tetrofosmin gated SPECT 
imaging in patients with left bundle branch block. We followed 101 consecutive patients 
with a left bundle branch block using technetium-99m tetrofosmin gated SPECT imaging. 
The average follow-up was 1.24 years (max. 2.48). Hard endpoints were all-cause death and 
acute myocardial infarction. Event-free survival curves were obtained. Optimal cut-off points 
for left ventricular volumes and left ventricular ejection fraction to predict outcome were 
determined by receiver operating characteristic curve analysis. Ninety-four patients had an 
abnormal study, fifteen patients suffered a hard event (13 deaths).  Perfusion abnormalities 
were similar for patients with or without events. For left ventricular function parameters the 
survival curves were maximally separated when using cut-off volumes for end-diastolic volume 
>160 ml (p=0.019, HR 1.04 for hard events, p=0.024 HR 1.04 for all-cause death), and for 
end-systolic volume >100 ml (p=0.043 HR 1.04 for hard events, p=0.062 HR 1.04 for all-cause 
death), for left ventricular ejection fraction <35% (hard events p=0.013, HR 0.81, all-cause 
death p=0.047, HR 0.81). Therefore, we concluded that quantitative gated SPECT imaging in 
patients with left bundle branch block can be used for risk stratification. Patients with an end-
diastolic volume >160 ml or an end-systolic volume >100 ml or left ventricular ejection fraction 
< 35% are at increased risk for subsequent cardiac events.
106
An increased mortality and re-infarction have been noted in women after myocardial infarction 
compared to men. The large proportion of atypical symptoms, higher incidence of associated 
disease (e.g. hypertension, diabetes mellitus) and the higher age at presentation may account 
for the worse outcome. Exercise ECG has a lower diagnostic and prognostic accuracy in 
women. Appropriate non-invasive diagnostic testing is important in the early diagnosis and 
the risk stratification of women with suspected CAD.  Most data on prognostic value of the 
parameters assessed by gated SPECT have been obtained in a mixed gender population and 
may not be applicable to women. It has been shown that gender related differences in normal 
limits exist. 
In Chapter 5 we evaluated the incremental prognostic value of quantitative gated SPECT 
imaging in female patients. We followed 453 consecutive female patients. Average follow-up 
was 1.33 years (max. 2.55). Hard endpoints were cardiac death, acute myocardial infarction 
or documented ventricular fibrillation. Event-free survival curves were obtained. Optimal cut-
off values for left ventricular volumes, left ventricular ejection fraction and perfusion data to 
predict outcome were determined by receiver operating characteristic curve analysis. A total of 
236 patients had an abnormal study, of whom 27 patients experienced hard events (16 deaths) 
and 47 patients soft events. For hard events summed stress score and left ventricular ejection 
fraction, and for any cardiac event summed stress score showed independent incremental 
prognostic value. The survival curves were maximally separated when using cut-off values 
for summed stress score of # 22 and left ventricular ejection fraction < 52% (p<0.001, HR 
4.61 and p<0.001 HR 5.24 for summed stress score and left ventricular ejection fraction 
resp.), and summed stress score # 14 (p< 0.001 HR 3.76) for any cardiac event. We concluded 
that in female patients the perfusion and functional parameters derived from quantitative 
gated technetium-99m tetrofosmin SPECT imaging has incremental prognostic value and 
can adequately be used for cardiac risk assessment. Using quantitative gated SPECT, female 
patients with an left ventricular ejection fraction < 52% or an summed stress score #22 are at 
increased risk for subsequent hard events. Furthermore, patients with a summed stress score 
#14 are at increased risk for any cardiac events.  
Gated SPECT myocardial perfusion imaging allows the analysis of left ventricular perfusion and 
function during a single acquisition. The addition of left ventricular functional parameters to 
perfusion improves test specificity in patients with known or suspected coronary artery disease 
and hence diminishes the amount of borderline diagnoses. As gated SPECT provides reliable 
information on regional wall motion and thickening, left ventricular ejection fraction and left 
ventricular volumes, it is also a valuable tool in risk stratification. The improvement in survival 
after acute myocardial infarction resulted in a markedly increased population of patients with 
more or less extensive cardiac disease. Patients tend to be older and to have a more severe 
extent of disease. In this setting it becomes more important to go beyond establishing a 
diagnosis of coronary artery disease, and toward the level of risk stratification. This need for 
risk stratification applies to patients with either acute or chronic coronary artery disease. 
In Chapter 6 we give a review of the relevant literature on the prognostic value of SPECT 
imaging. Numerous studies have shown the incremental prognostic value of myocardial 
perfusion imaging.  Even after clinical assessment, exercise electrocardiography and coronary 
angiography. Especially, in patients at intermediate risk of CAD. Important variables for 



































   7
or perfusion defect, increased lung uptake of thallium, transient ischemic dilatation and 
left ventricular ejection fraction. Patients with a normal myocardial perfusion scan have an 
excellent prognosis with a very low annual cardiac death and myocardial infarction rate (< 
1%/year). High-risk patients (annualized event rates 3% or higher) are those with moderately 
to severely abnormal scans, multivessel perfusion abnormalities or a SSS > 8 (hypoperfused 
myocardium of > 10%). Patients with abnormal scans have on average an annual event rate 
of 6.7% (CD or MI). Women with severe abnormalities may have worse outcome than men 
with severe abnormalities. The prognostic value of MPI is equivalent in DM and nondiabetic. 
Diabetic women with mildly perfusion abnormalities had twice the annual mortality rate 
(3.3%) of diabetic men with the same abnormalities (1.6%).  Nondiabetic women with normal, 
moderately abnormal, and severely abnormal images have an annual major adverse cardiac 
events rate of 0.8%, 2.8%, and 6.1% respectively; the cardiac event rates increase to 1.6%, 
4.1%, and 8.5 % in diabetic women. Gated SPECT imaging may be used for stratification 
of candidates for revascularization as it allows the analysis of residual wall thickening in a 
region with a fixed perfusion defect or depressed wall motion in a region with a moderate 
or mild perfusion defect indicating hibernation. Gated SPECT provides important additional 
information beyond myocardial perfusion imaging alone, which could have major clinical 
implications for optimal patient management. 
General conclusions
The software program (the QGS-software, version 2.0, revision A”) of the automated regional 
quantitative gated SPECT is robust and shows excellent reproducibility. However, special care 
must be taken into account in the presence of large defects or spurious activity in close proximity. 
In patients with previous myocardial infarction assessment of left ventricular function must be 
done in rest, because left ventricular function post-stress may not represent true resting left 
ventricular function. Furthermore, the presence of reversible ischemia is not a prerequisite for 
the development of myocardial stunning in patients with a previous myocardial infarction. 
Quantitative gated single photon emission computed tomography provides additional 
information beyond myocardial perfusion alone in patients with (suspected) coronary artery 
disease. Especially, stress defect size and left ventricular function parameters assessed by 
gated SPECT show independent and incremental prognostic value in the different subgroups. 
At subgroup level we showed that gated SPECT can be used in risk stratification. It is possible 
to select those patients at increased risk of suffering a major adverse cardiac event. This will 
have major clinical implications for optimal patient management. Patients at increased risk 
could benefit from a more aggressive (invasive) therapy such as revascularization. Conersely, 
patients with smaller perfusion defects and/or normal left ventricular function benefit from a 
more conservative approach. 
Future perspectives
In search of the ideal approach to diagnose and assess the prognosis of patients with 
(suspected) coronary artery disease new nuclear devices, attenuation correction, reconstruction 
and processing algorithms have been developed. Paralleling the advances in instrumentation 
are novel approaches in radiotracer design. Herewith, substantial reductions in acquisition 
time have been achieved without sacrificing diagnostic quality. New clinical devices include 
high-count sensitivity cardiac SPECT systems that do not use conventional collimation and 
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the introduction of diagnostic-quality hybrid SPECT/CT or PET/CT systems. These high-count 
sensitivity cardiac SPECT systems provide significantly higher count sensitivity and better 
spatial resolution than the conventional myocardial SPECT systems. Combined SPECT/ PET and 
CT systems have an improved attenuation correction, resulting from the more accurate and 
precise attenuation map that is associated with CT. Also anatomical information (presence of 
coronary artery calcium and the degree of coronary artery luminal narrowing) assessed by CT 
adds information to functional data assessed by SPECT or PET studies. A combined system 
ensures efficient access to both image sets and allows the operators better control of patient 
orientation. Another advantage is the ability to perform complementary diagnostic studies in 
the same setting, making both of these studies more efficient and convenient for the patient. 
Much emphasis is placed on the diagnosis and treatment of cardiovascular disease at its 
earliest stages. The therapeutic response to early detection of cardiovascular disease will 
lead to improved patient outcome. Molecular imaging exploits specific molecular targets, 
pathways, or cellular processes. This enables to study the pattern of gene expression, cellular 
protein structure and function, and small-molecule metabolite profile to identify more specific 
markers of disease presence and cellular therapeutic responses. For example, pre-clinical small 
animal Ultra-single Photon Emission Computed Tomography (U-SPECT) has been developed. 
It enables to exploit the high-resolution content of pinhole projection data. This system has 
pushed the limits of SPECT into the sub-millimeter range, making them valuable molecular 
imaging tools capable of providing information unavailable from other modalities. It has a 
volumetric resolution on the order of 0.1 µL. Radioactively filled capillaries as small as 0.5 mm 
and separated by 0.5 mm can be distinguished clearly in reconstructions. One can monitor 
myocardial perfusion in the left and right ventricular walls, even structures as small as the 
papillary muscles.  The resolution is significantly better with U-SPECT than with traditional 
small animal SPECT and PET systems. The challenge for the future will be the translation of the 
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SAMENVATTING, CONCLUSIE EN TOEKOMSTPERPECTIEVEN
Samenvatting
In dit proefschrift werd de toegevoegde prognostische waarde van de functionele data, 
verkregen met “quantitative gated single photon emission computed tomography (SPECT)”, 
bij patiënten met (verdenking op) coronairlijden geëvalueerd. Veel studies zijn verricht om de 
prognostische waarde van myocardperfusiescintigrafie in een gemengde (niet geselecteerde) 
populatie te evalueren. De techniek werd op subgroepniveau geëvalueerd. Belangrijke perfusie 
dan wel functionele voorspellers voor een slechte cardiale uitkomst werden gedefinieerd. 
Hiernaast, werden verschillende analyses verricht om een optimale scheiding te realiseren 
tussen patiënten met een sterk verhoogd cardiaal risico en patiënten zonder verhoogd risico.
Verschillende technieken voor automatische kwantitatieve benadering van myocardperfusie-
scintigrafie zijn ontwikkeld om de bedieningsafhankelijkheid te minimaliseren en de 
reproduceerbaarheid te verhogen. Met betrekking tot de validatie van de Cedars-Sinai’s 
Quantitative SPECT (QGS) software, is de kruislinkse validatie met andere technieken op 
populatieniveau verricht. Elk falen bij bepaalde specifieke subgroepen zal verwateren door de 
grote hoeveelheid succesvolle analyses in de onderzochte gegeneraliseerde groep. De software 
van de QGS techniek is complex en valt in bepaalde gevallen terug op alternatieve algoritmen. 
Deze complexiteit maakt het moeilijk om kruislinkse validatie met andere technieken te 
verrichten. In hoofdstuk 2 werd op basis van systeem analyse de betrouwbaarheid van de 
kwantitatieve bepaling van linker ventrikel volumina (einddiastolische en eindsystolische), linker 
ventrikel ejectie fractie (LVEF) en de regionale segmentele linker ventrikel wandbeweging en 
wandverdikking geëvalueerd. Met deze benadering werd het algoritme werd op interfererende 
klinische condities geëvalueerd. De bedieningsafhankelijke factor van het algoritme bestond 
alleen uit de re-oriëntatie die de gebruiker van de software moet uitvoeren na de acquisitie van 
de ruwe data. De verdere verwerking van de data kan gemakkelijk constant worden gehouden. 
Een serie prototypen werd geselecteerd. De prototypen bestonden uit: a) normale perfusie, 
b) perfusie defecten in alle verschillende perfusie regio’s, c) perfusie scintigrafische studies bij 
patiënten met angiografisch bevestigde normale coronairarteriën, proximale (# 70% luminale 
stenose) 1 vat en meervats coronairlijden, en d) radiofarmacon “omgevingsactiviteit”. Bij het 
definiëren en re-oriënteren van de region-of-interest die het linker ventrikel moet bevatten 
moet de gebruiker 8 variabelen/ vrijheidsgraden aanpassen. De resultaten werden weergeven 
in variatie-coëfficiënten. Voor iedere vrijheidsgraad werd de variatie-coëfficiënt berekend. Een 
segment was niet robuust indien de variatie-coëfficiënt groter was dan 20% in 1 vrijheidsgraad, 
15% in tenminste 2 vrijheidsgraden, of 10% in tenminste 3 vrijheidsgraden. De resultaten 
toonden een uitstekende reproduceerbaarheid aan wat betreft de LVEF en linker ventrikel 
volumina. Een normaal perfusie scintigrafisch onderzoek en de verschillende prototypen 
coronairlijden toonden een uitstekende variatie-coëfficiënt (voor alle re-oriëntatie stappen 
[33/prototype]). Meestal < 5% voor linker ventrikel functie parameters. Echter, regionale 
linker ventrikel wandbeweging en wandverdikking werden minder betrouwbaar in geval van 
grote perfusie defecten of radiofarmacon “omgevingsactiviteit” in de buurt van het myocard 
(bijvoorbeeld darmactiviteit). Geconcludeerd werd dat de kwantitatieve automatische gated 
SPECT software (QGS) een uitstekende reproduceerbaarheid heeft. Gated acquisities van de 
inspanningsmyocardperfusie scintigrafische beelden, verkregen 30 minuten post-stress, tonen 
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minuten post-stress verkregen werden, geven de rust (post-stress) situatie weer. Meerdere 
studies toonden aan dat inspanningsgeïnduceerde ischemie post-stress linker ventrikel 
dysfunctie kan veroorzaken, waarschijnlijk op basis van stunning. Deze kan 60 minuten of 
zelfs langer aanhouden. Voor aanvang van een gated SPECT onderzoek is niet bekend welke 
patiënten inspanningsgeïnduceerde ischemie tonen. Daarom is het niet mogelijk om vooraf 
patiënten te selecteren die een gated studie in rust (i.p.v. post-stress) moeten ondergaan om 
de mogelijkheid van stunning (een lagere LVEF t.o.v. de rust situatie) te voorkomen. 
In hoofdstuk 3 werd bij patiënten met een doorgemaakt myocardinfarct de linker ventrikel 
post-stress functie vergeleken met linker ventrikel functie in rust. Daarnaast werd in deze 
patiëntengroep de invloed van de verschillende stress technieken (farmacologische stress t.o.v. 
conventionele inspanning) op de linker ventrikel functie bepaald. Achtenvijftig patiënten met 
een doorgemaakt myocardinfarct werden onderzochten. Bij alle patiënten werd de perfusie 
en LVEF bij de rust en post-stress acquisitie bepaald. De bepaling van de LVEF was uitstekend 
reproduceerbaar, binnen een marge van 2%. In 33 patiënten (57%) was de LVEF post-stress # 
2% lager dan de rust LVEF. De “matched control group”, bestaande uit 23 patiënten met een 
lage verdenking op coronairlijden, toonde geen significante verschillen in LVEF tussen post-
stress en rust (0.04%± 3.2%, p=ns). Echter, de patiënten met een doorgemaakt myocardinfarct 
toonden een significant lagere LVEF post-stress t.o.v. de rust (-1.9%± 4.2%, p=0.002). De 
aanwezigheid van ischemie, welke bij 16 patiënten (28%) voorkwam, had geen invloed op de 
verandering in LVEF post-stress t.o.v. rust (p=ns).  Deze bevinding betekent dat de aanwezigheid 
van reversibele ischemie geen voorwaarde is voor het ontstaan van stunning bij patiënten 
met een doorgemaakt myocardinfarct. Verder heeft de soort inspanning (conventionele 
inspanningstest of adenosine) geen invloed op de resultaten. Hieruit werd geconcludeerd dat 
bij patiënten met een doorgemaakt myocardinfarct, de linker ventrikel functie post-stress niet 
de ware rust linker ventrikel functie weerspiegelt. 
Een linker bundeltakblok (LBTB) patroon op het elektrocardiogram vermindert de diagnostische 
en prognostische waarde van myocardperfusiescintigrafie. 
In hoofdstuk 4 werd de toegevoegde prognostische waarde van kwantitatieve technetium-99m 
tetrofosmin gated SPECT scintigrafie bij patiënten met een LBTB bestudeerd. De gemiddelde 
duur van follow-up was 1.24 jaar (max. 2.48). Harde eindpunten waren “all-cause” mortaliteit 
en acuut myocardinfarct. Overlevingsgrafieken werden verkregen. Optimale afkappunten voor 
linker ventrikel volumina en LVEF voor risicostratificatie werden verkregen met behulp van 
receiver operating characteristic (ROC) curve analyse. Bij 94 patiënten toonde het scintigram 
perfusie afwijkingen, 15 patiënten bereikten een hard eindpunt (13 sterfgevallen). Patiënten 
met en zonder harde eindpunten toonden significante verschillen in perfusiedefecten. Ten 
aanzien van de linker ventrikel functie parameters konden de overlevingsgrafieken maximaal 
worden gescheiden indien voor einddiastolisch volume 160 ml (p=0.019, HR 1.04 voor harde 
eindpunten, p=0.024 HR 1.04 voor all-cause mortaliteit), voor eindsystolisch volume 100 ml 
(p=0.043 HR 1.04 voor harde eindpunten, p=0.062 HR 1.04 voor all-cause mortaliteit), voor 
LVEF 35% (harde eindpunten p=0.013, HR 0.81, all-cause mortaliteit p=0.047, HR 0.81) als 
afkappunten werd genomen. Hieruit werd geconcludeerd dat kwantitatieve gated SPECT 
scintigrafie gebruikt kan worden voor risicostratificatie bij patiënten met een LBTB. Patiënten 
met een einddiastolisch volume >160 ml of een eindsystolisch volume >100 ml of linker ventrikel 
ejectie fractie < 35% hebben een sterk verhoogd cardiaal risico.
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Vrouwen met een doorgemaakt myocardinfarct tonen een hoger mortaliteitsrisico en 
grotere aantallen re-infarcten t.o.v. mannelijke patiënten. Het grote aandeel presentaties met 
atypische klachten, hogere incidentie van geassocieerde ziekten (b.v. hypertensie, diabetes 
mellitus) en  de hogere leeftijd bij presentatie hebben een aandeel in de slechtere prognose. 
Een inspannings-ECG bij vrouwen heeft een lagere diagnostische en prognostische waarde. 
Adequate niet-invasieve diagnostische onderzoeken zijn belangrijk voor de vroege diagnostiek 
en risicostratificatie bij vrouwen met verdenking op coronairlijden. De meeste data over de 
prognostische waarde van de met gated SPECT verkregen linker ventrikel parameters werden 
verkregen in een gemengde (mannen en vrouwen) populatie en kunnen daarom niet zonder 
meer worden betrokken op de vrouwelijke patiënt. Het is bekend dat er geslachtsgebonden 
normaalwaarden bestaan. In hoofdstuk 5 werd de toegevoegde prognostische waarde van 
kwantitatieve gated SPECT scintigrafie bij de vrouwelijke patiënt onderzocht. Er werden 453 
opeenvolgende vrouwelijke patiënten gevolgd. De gemiddelde follow-up was 1.33 jaar (max. 
2.55). Harde eindpunten waren cardiale sterfte, acuut myocardinfarct of gedocumenteerd 
ventrikelfibrilleren. Overlevingsgrafieken werden vervaardigd. Ten aanzien van het voorspellen 
van eindpunten werden optimale grenzen voor linker ventrikel volumina, LVEF en perfusiedata 
berekend m.b.v. ROC analyse. In totaal toonden 236 patiënten een abnormale studie, waarvan 
27 patiënten een hard eindpunt (16 doden) en 47 patiënten en zacht eindpunt (revascularisatie 
procedure) bereikten. De totale “ summed stress score” en LVEF toonden een onafhankelijke 
toegevoegde prognostische waarde t.a.v. harde eindpunten.  De summed stress score toonde 
ook een onafhankelijke toegevoegde prognostische waarde t.a.v. zachte eindpunt. De 
overlevingsgrafieken werden maximaal gescheiden indien voor harde eindpunten een summed 
stress score van 22 en voor LVEF 52% als grens werd aangehouden (p<0.001, HR 4.61 en 
p<0.001 HR 5.24 voor summed stress score en linker ventrikel ejectie fractie respectievelijk). 
Voor alle eindpunt samen werd een summed stress score van 14 (p<0.001 HR 3.76) als grens 
genomen. Geconcludeerd kon worden dat bij de vrouwelijke patiënt de met kwantitatieve 
gated technetium-99m tetrofosmin verkregen linker ventrikel perfusie- en functiedata 
toegevoegde prognostische waarde heeft. Het kan derhalve gebruikt worden voor een 
adequate risicostratificatie. Vrouwen met een LVEF van < 52% of een summed stress score van 
#22 hebben een sterk verhoogd risico op een hard eindpunt. Verder, vrouwelijke patiënten 
met een summed stress score van #14 hebben een verhoogd risico op enig cardiaal eindpunt. 
Met gated SPECT myocardperfusiescintigrafie kan de linker ventrikel perfusie- en functiedata 
tijdens een enkele acquisitie worden verkregen. Het toevoegen van linker ventrikel functie 
parameters, bovenop perfusie, verbetert de specificiteit van de test bij patiënten met 
(verdenking op) coronairlijden en het vermindert het aantal diagnostische “grensgevallen”. 
Naast het feit dat gated SPECT betrouwbare informatie levert over regionale wandbeweging 
en wandverdikking, LVEF en linker ventrikel volumina, is het ook een waardevol instrument 
voor risicostratificatie. Verbeterde overlevingskansen na een doorgemaakt myocardinfarct 
resulteerde in een aanmerkelijk grotere populatie patiënten met min of meer uitgebreid 
cardiaallijden. De patiënt wordt ouder en heeft vaak een uitgebreide vorm van hart- en 
vaatziekte. Dit in achtnemend wordt het interessant om verder te gaan dan alleen het 
stellen van de diagnose coronairlijden en te streven naar een beleid dat gebaseerd is op 
risicostratificatie. De behoefte aan risicostratificatie heeft betrekking op patiënten met zowel 
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In hoofdstuk 6 werd in een overzicht gegeven over de huidige beschikbare relevante 
literatuur t.a.v. de prognostische waarde van myocard SPECT scintigrafie. Meerdere studies 
hebben een toegevoegde prognostische waarde van myocardperfusiescintigrafie beschreven. 
Zelfs na stratificatie op basis van klinische data, inspanningselektrocardiogram en coronair 
angiografie. Vooral bij patiënten met een “intermediate” risico op coronairlijden. Belangrijke 
variabelen voor risicostratificatie zijn type inspanningsonderzoek, uitgebreidheid en ernst 
van de ischemie en/of perfusie defect, verhoogde thallium opname in de longen, ischemisch 
gemedieerde linker ventrikel dilatatie en LVEF. Patiënten met een normaal perfusie scintigrafisch 
onderzoek hebben een uitstekende prognose met een zeer lage jaarlijkse incidentie 
myocardinfarct en/of mortaliteits (< 1%/jaar). Hoog risico patiënten (jaarlijks 3% of hoger 
kans op myocardinfarct en/of overlijden) zijn degenen met een matig tot ernstig afwijkend 
perfusiescintigram, met een persfusiepatroon passend bij meervatslijden of een summed 
stress score > 8 (verminderde perfusie in > 10% van het linker ventrikel). Het gemiddelde 
risico op een hard eindpunt (cardiale sterfte of myocardinfarct) bij een patiënt met een 
afwijkend myocardperfusiescintigram bedraagt 6.7%. Vrouwen met ernstige perfusiedefecten 
hebben een slechtere prognose dan mannen met ernstige perfusiedefecten. De prognostische 
waarde van myocardperfusiescintigrafie is hetzelfde bij patiënten met of zonder diabetes 
mellitus (DM). Echter, vrouwen met DM en kleine perfusiedefecten hebben een tweemaal 
zo groot mortaliteitsrisico (3.3% jaarlijks) t.o.v. diabetische mannen met dezelfde afwijkingen 
(1.6%). Niet-diabetische vrouwen met een normaal scintigram, gematigd afwijkend perfusie 
scintigram (10-15% van totale linker ventrikel) en ernstige perfusie afwijkingen (> 15% van de 
totale linker ventrikel) hebben een kans op ernstige cardiale gebeurtenissen (cardiale sterfte of 
myocardinfarct) van respectievelijk 0,8%/jaar, 2,8%/jaar en 6,1%/jaar; De incidentie stijgt naar 
1,6%, 4,1% en 8,5% bij diabetisch vrouwen. Gated SPECT scintigrafie kan worden gebruikt 
bij patiënten die in aanmerking komen voor revascularisatie. Behouden wandverdikking in een 
gebied met een persisterend perfusiedefect of verminderde wandbeweging in een gebied met 
milde of gematigde perfusiedefecten toont aan dat er sprake is van hibernatie in het betreffende 
gebied. Gated SPECT verschaft toegevoegde informatie bovenop myocardperfusiescintigrafie 
alleen, welke belangrijke klinische gevolgen kan hebben voor het patiëntenbeleid. 
Conclusies
Het software programma (de QGS software, version 2.0, revisor A”) van de automatisch 
regionale kwantitatieve gated SPECT is robuust en heeft een uitstekende reproduceerbaarheid. 
Echter, speciale aandacht is vereist bij aanwezigheid van grote perfusiedefecten of activiteit 
van het radiofarmacon in de nabije omgeving van het myocard. Bij patiënten met een 
myocardinfarct in de voorgeschiedenis zal analyse van de linker ventrikel functie moeten 
worden verricht in rust, gezien het feit dat bepaling van post-stress linker ventrikel functie 
niet de ware rust situatie kan weergeven. Verder, de aanwezigheid van reversibele ischemie is 
geen vereiste voor de ontwikkeling van myocard stunning bij patiënten met een doorgemaakt 
myocardinfarct. Kwantitatieve gated single photon emission computed tomografie verschaft 
bij patiënten met (verdenking op) coronairlijden additionele informatie bovenop informatie 
over myocardperfusie. Vooral de met gated SPECT verkregen inspanningsgerelateerde 
defectgrootte en de LVEF parameters tonen onafhankelijke en toegevoegde prognostische 
waarde bij de verschillende subgroepen. Dit proefschrift toont aan dat op subgroepniveau 
gated SPECT gebruikt kan worden voor risicostratificatie. Het is mogelijk om de patiënten met 
116
een sterk verhoogd cardiaal risico te selecteren. Dit heeft grote klinische betekenis voor optimale 
patiëntmanagement. Patiënten met een verhoogd cardiaal risico kunnen profijt hebben bij een 
agressieve (invasieve) therapie zoals revascularisatie. In tegenstelling tot patiënten met kleine 
perfusiedefecten en/of een normale linker ventrikel functie. Deze patiënten hebben profijt bij 
een meer conservatieve aanpak.
Toekomst perspectieven
In de zoektocht naar de ideale strategie voor het stellen van de diagnose en bepaling van de 
prognose bij patiënten met (verdenking op) coronairlijden zijn nieuwe nucleaire technieken, 
attenuatie correctie, reconstructie en proces algoritmen ontwikkeld. Parallel hieraan is de 
nieuwe aanpak in radiofarmaca design. Hierdoor is een substantiële reductie in acquisitieduur 
bereikt zonder negatieve gevolgen voor de diagnostische kwaliteit. Nieuwe klinische 
technieken betreffen o.a. high-count sensitivity cardiale SPECT systemen die geen gebruik 
maken van conventionele collimatoren en de introductie van hybride SPECT/CT of PET/CT. 
Deze high-count sensitivity cardiale SPECT systemen zorgen voor een significante hogere 
count sensitiviteit en een betere spatiële resolutie dan de conventionele myocardiale SPECT 
systemen. Gecombineerde SPECT/PET en CT systemen verbeterden de attenuatie correctie, 
die voortkomen uit de accurate en precieze attenuatie weergave van de CT. Ook anatomische 
informatie (aanwezigheid van calcium in coronair arteriën en de ernst van coronair arterie 
luminal vernauwing) verkregen met CT voegt belangrijke informatie toe aan functionele data 
verkregen met SPECT of PET studies. Een ander voordeel is de mogelijkheid om aanvullende 
diagnostische studies te verrichten in de zelfde onderzoekstijd, waardoor deze studies 
efficiënter en gebruiksvriendelijker zijn voor de patiënt.
Veel belangstelling is er voor diagnostiek en behandeling van de hart- en vaatziekten in haar 
vroegste fase. De therapeutische respons op vroege detectie van hart- en vaatziekte verbetert 
de prognose van de patiënt. Molecular imaging exploreert specifieke moleculaire doelen of 
cellulaire processen. Dit maakt het mogelijk om patronen van genexpressie, proteïne structuur 
en functie, en molecuul metabolietprofielen te bestuderen en om specifieke ziekte- en cellulaire 
therapeutische activiteitsmarkers te identificeren. Bijvoorbeeld met het pre-klinische Ultra-
single Photon Emission Computed Tomography (U-SPECT). Dit systeem heeft een volumetrische 
resolutie van 0,1 µL. Het is mogelijk om myocardperfusie van de linker en rechter ventrikel 
wanden bij b.v de muis weer te geven, met zelfs structuren zo groot als de papillairspieren. De 
resolutie is significant beter met U-SPECT dan met traditionele kleine dierenmodel SPECT en 
PET systemen.  De uitdaging voor de toekomst zal zijn om de omslag te maken van diermodel 
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